| 1 | tolerability | 7,958 |
| 2 | harms | 2,056 |
| 3 | disadvantages | 915 |
| 4 | pharmacodynamics | 807 |
| 5 | side-effect | 489 |
| 6 | reactogenicity | 298 |
| 7 | cons | 247 |
| 8 | inconvenience | 155 |
| 9 | affordability | 98 |
| 10 | exclusivity | 79 |
| 11 | toleration | 37 |
| 12 | soul | 35 |
| 13 | enablers | 26 |
| 14 | distributors | 24 |
| 15 | reusability | 22 |
| 16 | comprehensibility | 18 |
| 17 | c-termini | 17 |
| 18 | s-enantiomers | 14 |
| 19 | 135° | 13 |
| 20 | demerits | 12 |
| 21 | addictiveness | 11 |
| 22 | parcel | 11 |
| 23 | retrogradation | 11 |
| 24 | translatability | 11 |
| 25 | edibility | 10 |
| 26 | recyclability | 10 |
| 27 | bilaterality | 9 |
| 28 | macrocirculation | 9 |
| 29 | safeties | 9 |
| 30 | petioles | 8 |
| 31 | polypharmacology | 8 |
| 32 | sustainment | 8 |
| 33 | eohsp70 | 7 |
| 34 | erythroplakia | 7 |
| 35 | non-specificity | 7 |
| 36 | overexertion | 7 |
| 37 | overgeneralization | 7 |
| 38 | safety/toxicity | 7 |
| 39 | synopses | 7 |
| 40 | tolerability/safety | 7 |
| 41 | under-estimates | 7 |
| 42 | 5-positions | 6 |
| 43 | diabetogenicity | 6 |
| 44 | interrelatedness | 6 |
| 45 | r545 | 6 |
| 46 | suvrange | 6 |
| 47 | thorns | 6 |
| 48 | tp/rr | 6 |
| 49 | 4-bispeb | 5 |
| 50 | 5ht-uptake | 5 |
| 51 | adverse-events | 5 |
| 52 | b16arg | 5 |
| 53 | dbt2 | 5 |
| 54 | faithfulness | 5 |
| 55 | glutaminolysis | 5 |
| 56 | mid-segments | 5 |
| 57 | over-exploitation | 5 |
| 58 | p-ratios | 5 |
| 59 | posthydration | 5 |
| 60 | psychosomatics | 5 |
| 61 | reappraisals | 5 |
| 62 | ruggedness | 5 |
| 63 | safety/reactogenicity | 5 |
| 64 | ser7 | 5 |
| 65 | spreadability | 5 |
| 66 | t8-sacrum | 5 |
| 67 | 'ease | 4 |
| 68 | 3h-cholesterol | 4 |
| 69 | 4h-pyrans | 4 |
| 70 | 7-positions | 4 |
| 71 | 8-o-acetyl-sm | 4 |
| 72 | antibiotype | 4 |
| 73 | apico | 4 |
| 74 | b-19 | 4 |
| 75 | brahman-angus | 4 |
| 76 | chanesar | 4 |
| 77 | cslh1 | 4 |
| 78 | gsk1016790a | 4 |
| 79 | gstp-1 | 4 |
| 80 | mirror-words | 4 |
| 81 | mpqx | 4 |
| 82 | news-recipients | 4 |
| 83 | non-cap-lrti | 4 |
| 84 | olkin | 4 |
| 85 | paraplegia/hemiplegia | 4 |
| 86 | post-measures | 4 |
| 87 | reassurance-seeking | 4 |
| 88 | retranslocation | 4 |
| 89 | suvanine | 4 |
| 90 | wearability | 4 |
| 91 | work-ability | 4 |
| 92 | 11193c/c | 3 |
| 93 | 2-methyl-2,3-butanediol | 3 |
| 94 | 3-positions | 3 |
| 95 | 6-positions | 3 |
| 96 | actitest | 3 |
| 97 | apo-a4 | 3 |
| 98 | asp145 | 3 |
| 99 | auct-∞ | 3 |
| 100 | biopiracy | 3 |
| 101 | blaoxa-10 | 3 |
| 102 | c-terminals | 3 |
| 103 | ce9afr | 3 |
| 104 | cellulites | 3 |
| 105 | cf3-dps | 3 |
| 106 | conservatories | 3 |
| 107 | contrykal | 3 |
| 108 | crr1 | 3 |
| 109 | da/dtmax | 3 |
| 110 | distichamine | 3 |
| 111 | doffing | 3 |
| 112 | dredging-meridian | 3 |
| 113 | esxgms | 3 |
| 114 | ff+sr | 3 |
| 115 | gpx-activity | 3 |
| 116 | hadd | 3 |
| 117 | heterophilia | 3 |
| 118 | hsp20.8 | 3 |
| 119 | hsp2667 | 3 |
| 120 | hspb5/hspb6 | 3 |
| 121 | iconography | 3 |
| 122 | il-6-ar | 3 |
| 123 | imb-15 | 3 |
| 124 | innocuousness | 3 |
| 125 | inter-dependency | 3 |
| 126 | isoprocarb | 3 |
| 127 | jungner | 3 |
| 128 | kappa-carrageenan | 3 |
| 129 | kv1.6 | 3 |
| 130 | ma-cii | 3 |
| 131 | majhi | 3 |
| 132 | mechanomyography | 3 |
| 133 | meltability | 3 |
| 134 | metohija | 3 |
| 135 | microbody | 3 |
| 136 | micro‑architecture | 3 |
| 137 | mir-193b* | 3 |
| 138 | neurofacilitation | 3 |
| 139 | non-receivers | 3 |
| 140 | para-positions | 3 |
| 141 | resolidification | 3 |
| 142 | scientificalness | 3 |
| 143 | sihsp19.6 | 3 |
| 144 | single-blinding | 3 |
| 145 | smd2 | 3 |
| 146 | time-to-completion | 3 |
| 147 | uv/tio2 | 3 |
| 148 | β-pinenes | 3 |
| 149 | -diameter | 2 |
| 150 | -lf | 2 |
| 151 | 1.5h/d | 2 |
| 152 | 1000s | 2 |
| 153 | 11-hydroxy-nbp | 2 |
| 154 | 253-264 | 2 |
| 155 | 3,5-diethynylpyridine | 2 |
| 156 | 3,5-dihydroxybenzoate | 2 |
| 157 | 3-o-monoacetylation | 2 |
| 158 | 461-479 | 2 |
| 159 | 553.7415mg/kg | 2 |
| 160 | a2059 | 2 |
| 161 | air-cooling | 2 |
| 162 | al7cr | 2 |
| 163 | ascensia® | 2 |
| 164 | associativity | 2 |
| 165 | at2-receptors | 2 |
| 166 | auc0infinity | 2 |
| 167 | beamformers | 2 |
| 168 | bedclothes | 2 |
| 169 | bio-prospecting | 2 |
| 170 | bribery | 2 |
| 171 | c-levels | 2 |
| 172 | c.glaucophylla | 2 |
| 173 | c= | 2 |
| 174 | cahsp18 | 2 |
| 175 | capillin | 2 |
| 176 | ccl8 | 2 |
| 177 | cd4cd25 | 2 |
| 178 | cefepime/tazobactam | 2 |
| 179 | chaetotaxy | 2 |
| 180 | clpx | 2 |
| 181 | dehydroepiandrosterone/pregnenolone | 2 |
| 182 | detyrosination | 2 |
| 183 | disempowerment | 2 |
| 184 | distance-to-water | 2 |
| 185 | distillates | 2 |
| 186 | donja | 2 |
| 187 | eco-toxicity | 2 |
| 188 | embase.date | 2 |
| 189 | erythocytes | 2 |
| 190 | expulsation | 2 |
| 191 | fentanyl-dexmedetomidine | 2 |
| 192 | fruit/berries/juice | 2 |
| 193 | fsmm26 | 2 |
| 194 | gangrenes | 2 |
| 195 | gem/oxaliplatin | 2 |
| 196 | giblets | 2 |
| 197 | gl-ex | 2 |
| 198 | heat-patterns | 2 |
| 199 | history/evidence | 2 |
| 200 | holzbach | 2 |
| 201 | hsp50 | 2 |
| 202 | hsp90/grα | 2 |
| 203 | hypermotility | 2 |
| 204 | hyporreflexie | 2 |
| 205 | igκ | 2 |
| 206 | ile932 | 2 |
| 207 | instigator | 2 |
| 208 | islampur | 2 |
| 209 | jtc-801 | 2 |
| 210 | lasting-time | 2 |
| 211 | laureliopsis | 2 |
| 212 | lc90s | 2 |
| 213 | ldh-b | 2 |
| 214 | lifestyle-factors | 2 |
| 215 | lt90s | 2 |
| 216 | maeil4 | 2 |
| 217 | makhzan | 2 |
| 218 | mast-6 | 2 |
| 219 | medline.date | 2 |
| 220 | micron-flowers | 2 |
| 221 | mri-lvh | 2 |
| 222 | nam26-15a | 2 |
| 223 | nano-scales | 2 |
| 224 | nitzschia | 2 |
| 225 | non-her2-genes | 2 |
| 226 | non-spvc | 2 |
| 227 | noninternalization | 2 |
| 228 | nontransfer | 2 |
| 229 | ny-198 | 2 |
| 230 | octasonol | 2 |
| 231 | ogl | 2 |
| 232 | orf57 | 2 |
| 233 | pi828 | 2 |
| 234 | pid3 | 2 |
| 235 | placement/removal | 2 |
| 236 | post-c | 2 |
| 237 | post-measurements | 2 |
| 238 | postintroduction | 2 |
| 239 | pre-2 | 2 |
| 240 | prescribability | 2 |
| 241 | probtec | 2 |
| 242 | provenience | 2 |
| 243 | rbmhsp-70 | 2 |
| 244 | reprimo | 2 |
| 245 | rs4953023 | 2 |
| 246 | rxralpha | 2 |
| 247 | satisfaction-with-hospital | 2 |
| 248 | second-tur | 2 |
| 249 | seed-targeting | 2 |
| 250 | self-fulfillment | 2 |
| 251 | sert-p601a/g602a | 2 |
| 252 | short-courses | 2 |
| 253 | skm2 | 2 |
| 254 | slu24a | 2 |
| 255 | sportsmanship | 2 |
| 256 | stmn3 | 2 |
| 257 | sub-species | 2 |
| 258 | t-3-mpe | 2 |
| 259 | time-responses | 2 |
| 260 | tomentosin | 2 |
| 261 | tricellulin | 2 |
| 262 | underfill | 2 |
| 263 | urine-parameters | 2 |
| 264 | xianling | 2 |
| 265 | yy2 | 2 |
| 266 | z-axes | 2 |
| 267 | α1β1 | 2 |
| 268 | δgra= | 2 |
| 269 | νasno2 | 2 |
| 270 | '1:2 | 1 |
| 271 | 'coalescence | 1 |
| 272 | 'doubling | 1 |
| 273 | 'extraction | 1 |
| 274 | 'jadu | 1 |
| 275 | 'localisation | 1 |
| 276 | 'perceptions | 1 |
| 277 | 'reinforcement | 1 |
| 278 | 'representations | 1 |
| 279 | 'stuffy | 1 |
| 280 | 'yakkan | 1 |
| 281 | -604c/1192a | 1 |
| 282 | -benefit | 1 |
| 283 | -sialylation | 1 |
| 284 | 0.17-fold | 1 |
| 285 | 0.24±0.04mg | 1 |
| 286 | 0.500mg | 1 |
| 287 | 0.65g/100ml | 1 |
| 288 | 0.6g/l | 1 |
| 289 | 0.6mg/kg | 1 |
| 290 | 0.7g/l | 1 |
| 291 | 0.8-1.5mg/kg | 1 |
| 292 | 09/2006 | 1 |
| 293 | 1,1,1,3,3,3 | 1 |
| 294 | 1,3,4-thiadiazolium- | 1 |
| 295 | 1,4-additions | 1 |
| 296 | 1-nh | 1 |
| 297 | 1.0pj/a | 1 |
| 298 | 1.13±1.22 | 1 |
| 299 | 1.2.6 | 1 |
| 300 | 1.9ng | 1 |
| 301 | 105.61tons | 1 |
| 302 | 11-nor- | 1 |
| 303 | 110,931 | 1 |
| 304 | 1134khz | 1 |
| 305 | 126+/-10/75+/-7mmhg | 1 |
| 306 | 14-3-3a | 1 |
| 307 | 140.3±46.3 | 1 |
| 308 | 14u/mg | 1 |
| 309 | 153+21 | 1 |
| 310 | 15nm | 1 |
| 311 | 16gpa | 1 |
| 312 | 17-s | 1 |
| 313 | 183-bp | 1 |
| 314 | 19,316 | 1 |
| 315 | 19-methyl | 1 |
| 316 | 192-198 | 1 |
| 317 | 196.69 | 1 |
| 318 | 1cc | 1 |
| 319 | 2'-ome-4'-selenorna | 1 |
| 320 | 2,3-o-disulfate-d-galactose | 1 |
| 321 | 2,6-xylidine | 1 |
| 322 | 2-oxadiazole-substituted | 1 |
| 323 | 2000hz | 1 |
| 324 | 2002/'03 | 1 |
| 325 | 21-monosulfates | 1 |
| 326 | 21.95+/-6.79 | 1 |
| 327 | 216-221 | 1 |
| 328 | 22.5μg | 1 |
| 329 | 25.3g/l | 1 |
| 330 | 26±4.4 | 1 |
| 331 | 27.55 | 1 |
| 332 | 272.1 | 1 |
| 333 | 28,849- | 1 |
| 334 | 283.5μg | 1 |
| 335 | 29.1+/-0.8g | 1 |
| 336 | 3'-c-methyl-β-d-allopyranonucleosides | 1 |
| 337 | 3'-fragments | 1 |
| 338 | 3'-phosphoramidites | 1 |
| 339 | 3,341 | 1 |
| 340 | 3,4'-substitution | 1 |
| 341 | 3-amidopiperidines | 1 |
| 342 | 3-chlorobiphenyl | 1 |
| 343 | 3-mercapto-1,2,4-4h-triazole | 1 |
| 344 | 3.24+/-0.28 | 1 |
| 345 | 30.12.2012 | 1 |
| 346 | 30/94 | 1 |
| 347 | 300-1800μg/g | 1 |
| 348 | 31/05 | 1 |
| 349 | 350pg/ml | 1 |
| 350 | 3=duality | 1 |
| 351 | 4'-selenoguanosine | 1 |
| 352 | 4,9-isomers | 1 |
| 353 | 4,949 | 1 |
| 354 | 4-chloropyridine | 1 |
| 355 | 400µl | 1 |
| 356 | 40km | 1 |
| 357 | 414.15 | 1 |
| 358 | 4140.3 | 1 |
| 359 | 42,694 | 1 |
| 360 | 5-o-positions | 1 |
| 361 | 5.0mg | 1 |
| 362 | 5.77-5.93 | 1 |
| 363 | 5/2010 | 1 |
| 364 | 50-weeks | 1 |
| 365 | 53164.84 | 1 |
| 366 | 568mg | 1 |
| 367 | 5779 | 1 |
| 368 | 580°c | 1 |
| 369 | 65gy | 1 |
| 370 | 6b11ab2 | 1 |
| 371 | 720.91 | 1 |
| 372 | 75-d | 1 |
| 373 | 7t3 | 1 |
| 374 | 7years-181 | 1 |
| 375 | 8'-positions | 1 |
| 376 | 85.36° | 1 |
| 377 | 9'-positions | 1 |
| 378 | 9-positions | 1 |
| 379 | 9days | 1 |
| 380 | a-bonding | 1 |
| 381 | a53t-mutation | 1 |
| 382 | absenteeism.data | 1 |
| 383 | acceptabililty | 1 |
| 384 | acetylspiramycin | 1 |
| 385 | acquisition/retention | 1 |
| 386 | actionability | 1 |
| 387 | ad41 | 1 |
| 388 | adamussium | 1 |
| 389 | addition/protonolysis | 1 |
| 390 | adolescents.because | 1 |
| 391 | after-study | 1 |
| 392 | after-test | 1 |
| 393 | ager-3 | 1 |
| 394 | ala333 | 1 |
| 395 | ala387 | 1 |
| 396 | alkali-extractability | 1 |
| 397 | alooh | 1 |
| 398 | alsо | 1 |
| 399 | ameliorability | 1 |
| 400 | aminodarone | 1 |
| 401 | anisodus | 1 |
| 402 | anlagebedingter | 1 |
| 403 | anti-conformations | 1 |
| 404 | anti-geometry | 1 |
| 405 | anti-p504s | 1 |
| 406 | anticardiolipins | 1 |
| 407 | antimicrobial-performance | 1 |
| 408 | antiogenesis | 1 |
| 409 | ara-supplementation | 1 |
| 410 | arabic-dominant | 1 |
| 411 | asp104 | 1 |
| 412 | asp114 | 1 |
| 413 | asp156 | 1 |
| 414 | astacin-like | 1 |
| 415 | auc0-168h/0-336h | 1 |
| 416 | autecology | 1 |
| 417 | autoreproduction | 1 |
| 418 | avoidability | 1 |
| 419 | axel | 1 |
| 420 | bactrin | 1 |
| 421 | baicelin | 1 |
| 422 | balm-mint | 1 |
| 423 | bapwv/caix | 1 |
| 424 | basc2o4 | 1 |
| 425 | bastions | 1 |
| 426 | bax/bcl | 1 |
| 427 | baxk | 1 |
| 428 | below-expected-levels | 1 |
| 429 | beta-epimers | 1 |
| 430 | bfmd | 1 |
| 431 | bio-sources | 1 |
| 432 | bio-tolerance | 1 |
| 433 | biological/quality | 1 |
| 434 | bioregulation | 1 |
| 435 | bis-hydrazones | 1 |
| 436 | bj/291/09 | 1 |
| 437 | björn | 1 |
| 438 | blandm | 1 |
| 439 | block-copolymerization | 1 |
| 440 | blowdown | 1 |
| 441 | buchanania | 1 |
| 442 | byname | 1 |
| 443 | c-ch3 | 1 |
| 444 | c15-acetylenic | 1 |
| 445 | c=2317+/-146 | 1 |
| 446 | carbonil/mg | 1 |
| 447 | cardio-selectivity | 1 |
| 448 | carl-friedrich | 1 |
| 449 | catguts | 1 |
| 450 | cd16/ | 1 |
| 451 | cdc2-tyr15 | 1 |
| 452 | cdia | 1 |
| 453 | centricities | 1 |
| 454 | cgi-seve | 1 |
| 455 | ch3-substituted | 1 |
| 456 | ch3mgbr | 1 |
| 457 | ch4/h2-rich | 1 |
| 458 | chirurgia | 1 |
| 459 | chloraemia | 1 |
| 460 | chloroform-fractions | 1 |
| 461 | chlorphenoxamine | 1 |
| 462 | chon | 1 |
| 463 | choreography | 1 |
| 464 | cirrhoses | 1 |
| 465 | client-centeredness | 1 |
| 466 | clinico-pathomorphology | 1 |
| 467 | clonogenesis | 1 |
| 468 | clysterizing | 1 |
| 469 | co-linearity | 1 |
| 470 | coaddition | 1 |
| 471 | coadministriation | 1 |
| 472 | codas-verapamil | 1 |
| 473 | coevaporation | 1 |
| 474 | cofounder | 1 |
| 475 | coisolation | 1 |
| 476 | cold-tolerances | 1 |
| 477 | cologarithm | 1 |
| 478 | colony-levels | 1 |
| 479 | community-levels | 1 |
| 480 | competitive-uncompetitive | 1 |
| 481 | concealment.most | 1 |
| 482 | conidiomata | 1 |
| 483 | contamination/estimation | 1 |
| 484 | contras | 1 |
| 485 | control.none | 1 |
| 486 | corneal® | 1 |
| 487 | corporació | 1 |
| 488 | corrosion-resistance | 1 |
| 489 | coryphaei | 1 |
| 490 | cost-effectivenesss | 1 |
| 491 | cost-effictveness | 1 |
| 492 | cost/lyg | 1 |
| 493 | craterispermum | 1 |
| 494 | creutzfeldt | 1 |
| 495 | critical-reflection | 1 |
| 496 | crp-predictors | 1 |
| 497 | cryo-stress | 1 |
| 498 | cryptocoryne | 1 |
| 499 | cyp4a10 | 1 |
| 500 | cyth1-4 | 1 |
| 501 | cytotoxicicty | 1 |
| 502 | cytotoxictiy | 1 |
| 503 | dcw1 | 1 |
| 504 | de-organization | 1 |
| 505 | deaurative | 1 |
| 506 | decabdes | 1 |
| 507 | dedicator | 1 |
| 508 | deemphasization | 1 |
| 509 | defattening | 1 |
| 510 | deferred/adjuvant | 1 |
| 511 | delayers | 1 |
| 512 | delphinium | 1 |
| 513 | denticity | 1 |
| 514 | deois | 1 |
| 515 | deolindo | 1 |
| 516 | dequenching | 1 |
| 517 | described-mainly | 1 |
| 518 | desulfurylation | 1 |
| 519 | detorquing | 1 |
| 520 | development/university | 1 |
| 521 | diauc | 1 |
| 522 | diazepam.meta-analysis | 1 |
| 523 | dichotomitin | 1 |
| 524 | digalactosyl-diglycerides | 1 |
| 525 | dihydralazin | 1 |
| 526 | dil-labeled | 1 |
| 527 | dis-adoption | 1 |
| 528 | discomplexation | 1 |
| 529 | displacement/folding | 1 |
| 530 | displacement/neutralisation | 1 |
| 531 | disposes | 1 |
| 532 | distal-halves | 1 |
| 533 | distributionn | 1 |
| 534 | don-upregulation | 1 |
| 535 | dose-comparisons | 1 |
| 536 | downstrokes | 1 |
| 537 | dsm-iv-classification | 1 |
| 538 | duration-time | 1 |
| 539 | dys-function | 1 |
| 540 | dyspepsia/abdominal | 1 |
| 541 | e-indexes | 1 |
| 542 | ea-dt | 1 |
| 543 | ec90s | 1 |
| 544 | effect/side-effect | 1 |
| 545 | elecctroacupuncture | 1 |
| 546 | eliminators | 1 |
| 547 | ellipro | 1 |
| 548 | eloquence | 1 |
| 549 | emilienne-rose | 1 |
| 550 | endosonography/doppler | 1 |
| 551 | endurance-is | 1 |
| 552 | energy-depletion | 1 |
| 553 | energy-domains | 1 |
| 554 | entercocci | 1 |
| 555 | ep-cp2 | 1 |
| 556 | epidemiology-bips | 1 |
| 557 | epuraea | 1 |
| 558 | erl1576 | 1 |
| 559 | errhysis | 1 |
| 560 | esms | 1 |
| 561 | et-rb | 1 |
| 562 | ethanol-responsive | 1 |
| 563 | ethicity | 1 |
| 564 | eumorphism | 1 |
| 565 | eveness | 1 |
| 566 | everusers | 1 |
| 567 | exaceration | 1 |
| 568 | exercise'.date | 1 |
| 569 | exobidentate | 1 |
| 570 | extra-value | 1 |
| 571 | exurbs | 1 |
| 572 | facilitation/co-ordination | 1 |
| 573 | falsehood | 1 |
| 574 | fantastyczne | 1 |
| 575 | farm-numbers | 1 |
| 576 | fatigue/loss | 1 |
| 577 | fe-bearing | 1 |
| 578 | fe3c | 1 |
| 579 | feasibility-of-use | 1 |
| 580 | filtrates/antibiotics | 1 |
| 581 | flabbiness | 1 |
| 582 | fosc2 | 1 |
| 583 | foxo3a-phosphorylation | 1 |
| 584 | fracture-dislocations | 1 |
| 585 | fracure | 1 |
| 586 | free-exciton | 1 |
| 587 | freedom/rights | 1 |
| 588 | g-browser | 1 |
| 589 | galiomycin | 1 |
| 590 | gansull-62110372 | 1 |
| 591 | gastro-sparing | 1 |
| 592 | geneticization | 1 |
| 593 | gfp-tagging | 1 |
| 594 | ghareghoroot | 1 |
| 595 | glicidic | 1 |
| 596 | glu232 | 1 |
| 597 | glu371 | 1 |
| 598 | glu59 | 1 |
| 599 | glücklich | 1 |
| 600 | gnrh-administered | 1 |
| 601 | gog-0172 | 1 |
| 602 | graphing | 1 |
| 603 | grbio | 1 |
| 604 | grimontia | 1 |
| 605 | gueltas | 1 |
| 606 | gv2 | 1 |
| 607 | hacat-2 | 1 |
| 608 | haemostasia | 1 |
| 609 | handcuff | 1 |
| 610 | hap14 | 1 |
| 611 | haploglossa | 1 |
| 612 | hba2- | 1 |
| 613 | heat-inhibition | 1 |
| 614 | heliconema | 1 |
| 615 | hetero-dimerization | 1 |
| 616 | hetero-fret | 1 |
| 617 | hev-4 | 1 |
| 618 | high-tertiles | 1 |
| 619 | hindbrains | 1 |
| 620 | hoarsness | 1 |
| 621 | homa-ia | 1 |
| 622 | homa-ir-index | 1 |
| 623 | homobenization | 1 |
| 624 | homol-d | 1 |
| 625 | homozygotization | 1 |
| 626 | hospital-length | 1 |
| 627 | hsv-2-dna | 1 |
| 628 | hurubayashi | 1 |
| 629 | hybanthus | 1 |
| 630 | hydration-dependence | 1 |
| 631 | hydrochlorothiazide/amiloride | 1 |
| 632 | hyermagnesuria | 1 |
| 633 | hyper-activity | 1 |
| 634 | hyper-production | 1 |
| 635 | hyperadhesivity | 1 |
| 636 | hypertrophy/degeneration | 1 |
| 637 | hypoplastia | 1 |
| 638 | id-test | 1 |
| 639 | identifcation | 1 |
| 640 | ifn-γ-treatment | 1 |
| 641 | il-1β1 | 1 |
| 642 | il‑β | 1 |
| 643 | immuno-probing | 1 |
| 644 | immunome | 1 |
| 645 | immuphenotypic | 1 |
| 646 | inaptness | 1 |
| 647 | inbalance | 1 |
| 648 | incidence/duration | 1 |
| 649 | indium-promoted | 1 |
| 650 | infant.models | 1 |
| 651 | infantilization | 1 |
| 652 | influx/efflux | 1 |
| 653 | infracommunities | 1 |
| 654 | interanalysis | 1 |
| 655 | intra-breath | 1 |
| 656 | intra-reproducibility | 1 |
| 657 | investigator-rating | 1 |
| 658 | isaba14 | 1 |
| 659 | isolation/purification | 1 |
| 660 | jeff | 1 |
| 661 | jinghou | 1 |
| 662 | joyeuxiella | 1 |
| 663 | judications | 1 |
| 664 | juicing | 1 |
| 665 | kaishihen | 1 |
| 666 | kanton | 1 |
| 667 | katabi | 1 |
| 668 | kca2.2 | 1 |
| 669 | kinetics/duration | 1 |
| 670 | kotalagenin | 1 |
| 671 | kpl-4 | 1 |
| 672 | ktcd15 | 1 |
| 673 | l-erythro- | 1 |
| 674 | l-monomenthyl | 1 |
| 675 | l289 | 1 |
| 676 | l5s1 | 1 |
| 677 | ldl-subfraction | 1 |
| 678 | lengths/heights | 1 |
| 679 | leucojum | 1 |
| 680 | lheidli | 1 |
| 681 | libido/potency | 1 |
| 682 | licaria | 1 |
| 683 | limnocythere | 1 |
| 684 | lipoprotein-metabolism | 1 |
| 685 | livertox | 1 |
| 686 | lomflox | 1 |
| 687 | lys331 | 1 |
| 688 | madhav | 1 |
| 689 | magnetoelasticity | 1 |
| 690 | maianthemum | 1 |
| 691 | maintanence | 1 |
| 692 | maintenance/reverberation | 1 |
| 693 | malazzesia | 1 |
| 694 | masf | 1 |
| 695 | mcgill-quality | 1 |
| 696 | mdkrps | 1 |
| 697 | merchandizing | 1 |
| 698 | meshasringi | 1 |
| 699 | mesocotyls | 1 |
| 700 | meta-rr | 1 |
| 701 | metastatisation | 1 |
| 702 | metohi | 1 |
| 703 | micro-location | 1 |
| 704 | microcavitation | 1 |
| 705 | microfibrosis | 1 |
| 706 | micromegakaryocyte | 1 |
| 707 | mid-term-follow-up | 1 |
| 708 | midazolam.assessment | 1 |
| 709 | millimeter/degree | 1 |
| 710 | minimizing-by | 1 |
| 711 | misinsertion | 1 |
| 712 | mispecification | 1 |
| 713 | mixing/absorption | 1 |
| 714 | monotetrahydropyranylation | 1 |
| 715 | mortalitysahsubarachnoid | 1 |
| 716 | moussonia | 1 |
| 717 | mrxs | 1 |
| 718 | ms-self | 1 |
| 719 | mtx.harmsthere | 1 |
| 720 | multi-horseradish | 1 |
| 721 | multidisciplinarity | 1 |
| 722 | multiplicity/redundancy | 1 |
| 723 | mutagenecity | 1 |
| 724 | n-protection | 1 |
| 725 | nature/severity | 1 |
| 726 | near-normalisation | 1 |
| 727 | neo-ι-carrahexaose | 1 |
| 728 | neobuccinum | 1 |
| 729 | neurotolerability | 1 |
| 730 | nhp-pain | 1 |
| 731 | nickeltitanium | 1 |
| 732 | nicotine-both | 1 |
| 733 | nido-shaped | 1 |
| 734 | nimodipine-method | 1 |
| 735 | nmh-th-4 | 1 |
| 736 | non-adoption | 1 |
| 737 | non-pfc | 1 |
| 738 | non-reaming | 1 |
| 739 | non-requirement | 1 |
| 740 | non-resurfacing | 1 |
| 741 | non-shedders | 1 |
| 742 | non-snorers | 1 |
| 743 | nonmembers | 1 |
| 744 | nonprostitutes | 1 |
| 745 | nonrecyclability | 1 |
| 746 | nonrisks | 1 |
| 747 | nonstandardisation | 1 |
| 748 | nonwelders | 1 |
| 749 | notozulia | 1 |
| 750 | nucleustide | 1 |
| 751 | number/severity | 1 |
| 752 | nwib-05 | 1 |
| 753 | nxk6-1 | 1 |
| 754 | n¹-position | 1 |
| 755 | o-n-acetyl | 1 |
| 756 | odd-number | 1 |
| 757 | oligo-glycosides | 1 |
| 758 | oncoba | 1 |
| 759 | optical-spatial | 1 |
| 760 | oralcefalosporins | 1 |
| 761 | organification | 1 |
| 762 | ortho-metallation | 1 |
| 763 | ortho-orientations | 1 |
| 764 | osteo-fixation | 1 |
| 765 | ostheosynthesis | 1 |
| 766 | other-ratings | 1 |
| 767 | ovafolinin | 1 |
| 768 | ovarian-hormone-dependence | 1 |
| 769 | over-scheduling | 1 |
| 770 | overadministration | 1 |
| 771 | overdevelopment | 1 |
| 772 | overinterpretation | 1 |
| 773 | overtitration | 1 |
| 774 | p-30 | 1 |
| 775 | p-conditions | 1 |
| 776 | p-duration | 1 |
| 777 | p-nkcc2 | 1 |
| 778 | pace-mapping | 1 |
| 779 | papulo-nodular | 1 |
| 780 | papulovesicle | 1 |
| 781 | paracolobactrum | 1 |
| 782 | parcial | 1 |
| 783 | paris.participants | 1 |
| 784 | partial-thromboplastin-time | 1 |
| 785 | pathopsychology | 1 |
| 786 | pblood | 1 |
| 787 | pcsk7 | 1 |
| 788 | pectinifrons | 1 |
| 789 | pedobarography | 1 |
| 790 | peg-ifn/rbv-therapy | 1 |
| 791 | pellet-pressure | 1 |
| 792 | pentaruthenium | 1 |
| 793 | peptidyl-glycine-α-amidating | 1 |
| 794 | perceptions/opinions | 1 |
| 795 | perio- | 1 |
| 796 | peritoneography | 1 |
| 797 | permissivity | 1 |
| 798 | pertinency | 1 |
| 799 | pet28a- | 1 |
| 800 | ph10.5 | 1 |
| 801 | phenylosazones | 1 |
| 802 | pherthima | 1 |
| 803 | phleboscleroobliteration | 1 |
| 804 | phlebotomists | 1 |
| 805 | phospho-pka | 1 |
| 806 | phosphorodiamidates | 1 |
| 807 | physconia | 1 |
| 808 | pimr | 1 |
| 809 | piperidine-3-ol-derived | 1 |
| 810 | piperidinyl-3,4- | 1 |
| 811 | pitangus | 1 |
| 812 | placebo+folfiri | 1 |
| 813 | placebolike | 1 |
| 814 | plva | 1 |
| 815 | pneumocysts | 1 |
| 816 | pneumonia/sepsis | 1 |
| 817 | polyglobulia | 1 |
| 818 | polymyxine-b | 1 |
| 819 | polysphaeridium | 1 |
| 820 | possbilities | 1 |
| 821 | post-40-minutes | 1 |
| 822 | post-graphenization | 1 |
| 823 | post-pe | 1 |
| 824 | postassesment | 1 |
| 825 | postdisinfection | 1 |
| 826 | postfasting | 1 |
| 827 | postfixation | 1 |
| 828 | posttraumatischer | 1 |
| 829 | praxias | 1 |
| 830 | precompensation | 1 |
| 831 | prescribing/titration | 1 |
| 832 | primer-dependent | 1 |
| 833 | pro142 | 1 |
| 834 | process-quality | 1 |
| 835 | pronominal | 1 |
| 836 | prostaglandin-induction | 1 |
| 837 | protein-retinoblastoma-binding | 1 |
| 838 | protégés | 1 |
| 839 | pseudo-elasticity | 1 |
| 840 | pseudo-outbreaks | 1 |
| 841 | pseudocroup | 1 |
| 842 | pseudopositivity | 1 |
| 843 | psychosurgery | 1 |
| 844 | psychrotrophs | 1 |
| 845 | pten-negativity | 1 |
| 846 | pteridine-containing | 1 |
| 847 | puericulture | 1 |
| 848 | pulsellum | 1 |
| 849 | pyruvate/ | 1 |
| 850 | q137 | 1 |
| 851 | qualty | 1 |
| 852 | r-104 | 1 |
| 853 | r=17 | 1 |
| 854 | radixes | 1 |
| 855 | rafflesia | 1 |
| 856 | ralitza | 1 |
| 857 | rar-alpha | 1 |
| 858 | rbc-amoxicillin-nitroimidazole | 1 |
| 859 | re-acceleration | 1 |
| 860 | re-internalization | 1 |
| 861 | re-living | 1 |
| 862 | recentness | 1 |
| 863 | receptaculum | 1 |
| 864 | reduction/discontinuance | 1 |
| 865 | reenforcement | 1 |
| 866 | refolding/degradation | 1 |
| 867 | regioslectivity | 1 |
| 868 | regressiveness | 1 |
| 869 | reinvigoration | 1 |
| 870 | remission/near-remission | 1 |
| 871 | remission/resolution | 1 |
| 872 | repack | 1 |
| 873 | repositioning/preparation | 1 |
| 874 | rerinse | 1 |
| 875 | resistant-strains | 1 |
| 876 | resoption | 1 |
| 877 | resubmersion | 1 |
| 878 | rhadinopsylla | 1 |
| 879 | rifampin-type | 1 |
| 880 | robins-mark-newey | 1 |
| 881 | rs12767583 | 1 |
| 882 | rs2298383 | 1 |
| 883 | rs2427824 | 1 |
| 884 | rs4648261 | 1 |
| 885 | rsahr2 | 1 |
| 886 | rsreg | 1 |
| 887 | rupivacaine | 1 |
| 888 | rv-em/am | 1 |
| 889 | rvsv-hsp70 | 1 |
| 890 | s549 | 1 |
| 891 | saccule | 1 |
| 892 | safetiness | 1 |
| 893 | safety/ae | 1 |
| 894 | safetyness | 1 |
| 895 | saltness | 1 |
| 896 | sarong | 1 |
| 897 | sawacillin | 1 |
| 898 | sbe4 | 1 |
| 899 | scutia | 1 |
| 900 | seed-grain | 1 |
| 901 | self-annealing | 1 |
| 902 | self-checking | 1 |
| 903 | self-cultivation | 1 |
| 904 | self-dosing | 1 |
| 905 | self-rationalisations | 1 |
| 906 | semi-quantity | 1 |
| 907 | septal-em/am | 1 |
| 908 | sequlae | 1 |
| 909 | ser80leu | 1 |
| 910 | ser864 | 1 |
| 911 | sert-i612q | 1 |
| 912 | sga-preterm | 1 |
| 913 | shaanxi10-h0091 | 1 |
| 914 | shangshi | 1 |
| 915 | shareholder | 1 |
| 916 | short-term.there | 1 |
| 917 | sickness-impact | 1 |
| 918 | sievings | 1 |
| 919 | sip-1 | 1 |
| 920 | sister.marcus | 1 |
| 921 | slackness | 1 |
| 922 | slave-owning | 1 |
| 923 | slc7a5 | 1 |
| 924 | slhsp20.8 | 1 |
| 925 | slr1 | 1 |
| 926 | sm+dm | 1 |
| 927 | smad-7 | 1 |
| 928 | smilacaceae | 1 |
| 929 | solvation/desolvation | 1 |
| 930 | sophus | 1 |
| 931 | soread | 1 |
| 932 | sortic | 1 |
| 933 | spallations | 1 |
| 934 | spermine-nonoate | 1 |
| 935 | sphenodesmus | 1 |
| 936 | spirituality.results | 1 |
| 937 | spo2nellcor | 1 |
| 938 | spore-load | 1 |
| 939 | spraining | 1 |
| 940 | steatitis | 1 |
| 941 | stem-wood | 1 |
| 942 | strengths/weaknesses | 1 |
| 943 | suas | 1 |
| 944 | subcoccinella | 1 |
| 945 | subregistries | 1 |
| 946 | subsequent-hfes | 1 |
| 947 | subsequent-lines | 1 |
| 948 | substenosis | 1 |
| 949 | sulphamethomidine | 1 |
| 950 | sum-severity | 1 |
| 951 | super-imposition | 1 |
| 952 | supervision/direction | 1 |
| 953 | supramarginal_r | 1 |
| 954 | sustention | 1 |
| 955 | switching/augmentation | 1 |
| 956 | symphyotrichum | 1 |
| 957 | synclisia | 1 |
| 958 | syncopating | 1 |
| 959 | systemization | 1 |
| 960 | sūn | 1 |
| 961 | t-91825 | 1 |
| 962 | t-terminated | 1 |
| 963 | t12-l4 | 1 |
| 964 | tagamyb2 | 1 |
| 965 | tanyu | 1 |
| 966 | tar-staining | 1 |
| 967 | task-dependence | 1 |
| 968 | tatarinow | 1 |
| 969 | teleology | 1 |
| 970 | temenothorax | 1 |
| 971 | temporal-comparison | 1 |
| 972 | tepidimicrobium | 1 |
| 973 | tetraphosphopeptides | 1 |
| 974 | thbe | 1 |
| 975 | the-state | 1 |
| 976 | thermo-electricity | 1 |
| 977 | thickning | 1 |
| 978 | thioesterification | 1 |
| 979 | thr473 | 1 |
| 980 | thrombocytopenia.elevation | 1 |
| 981 | throttling | 1 |
| 982 | time-ratio | 1 |
| 983 | time-to-deterioration | 1 |
| 984 | time-to-hatching | 1 |
| 985 | tissue-dependency | 1 |
| 986 | tocopherol-to-lipids | 1 |
| 987 | tolerabilty | 1 |
| 988 | top4 | 1 |
| 989 | torerability | 1 |
| 990 | torynurus | 1 |
| 991 | touluse | 1 |
| 992 | toxicity-profiles | 1 |
| 993 | trait-effects | 1 |
| 994 | trans-infection | 1 |
| 995 | trans-junction | 1 |
| 996 | transcatheterimplantation | 1 |
| 997 | transformation/decomposition | 1 |
| 998 | treg-dysfunction | 1 |
| 999 | tribonate | 1 |
| 1000 | triglycerides.studies | 1 |
| 1001 | type/level | 1 |
| 1002 | tyr16 | 1 |
| 1003 | tyrasine | 1 |
| 1004 | u4/u6 | 1 |
| 1005 | ultra-stabilised | 1 |
| 1006 | un-folding | 1 |
| 1007 | unaffordability | 1 |
| 1008 | unavailablility | 1 |
| 1009 | under-dose | 1 |
| 1010 | under-enhancement | 1 |
| 1011 | underdocumentations | 1 |
| 1012 | underloading | 1 |
| 1013 | underpower | 1 |
| 1014 | underprotection | 1 |
| 1015 | underrepresentations | 1 |
| 1016 | unhomogeneity | 1 |
| 1017 | union-application | 1 |
| 1018 | uration | 1 |
| 1019 | urban-slums | 1 |
| 1020 | uretectomy | 1 |
| 1021 | uretero-vesiconeostomy | 1 |
| 1022 | uv-detection | 1 |
| 1023 | value/effectiveness | 1 |
| 1024 | venerology | 1 |
| 1025 | verify3d | 1 |
| 1026 | washing-disinfection | 1 |
| 1027 | wcp14 | 1 |
| 1028 | web-rhetoric | 1 |
| 1029 | well-bonded | 1 |
| 1030 | whoqol-breff | 1 |
| 1031 | width/thickness | 1 |
| 1032 | withdrawl | 1 |
| 1033 | wladyslaw | 1 |
| 1034 | wolfhard | 1 |
| 1035 | wonca-quality | 1 |
| 1036 | work-conservation | 1 |
| 1037 | wrist/hands | 1 |
| 1038 | wysong | 1 |
| 1039 | włodzimierz | 1 |
| 1040 | y-axes | 1 |
| 1041 | ydrogen | 1 |
| 1042 | ym-71213 | 1 |
| 1043 | zc-fdps | 1 |
| 1044 | zozhi | 1 |
| 1045 | zygmunt | 1 |
| 1046 | α-internexin | 1 |
| 1047 | α-l-rhamnopyranoside | 1 |
| 1048 | α2-subunits | 1 |
| 1049 | β-d-galactopyranoside | 1 |
| 1050 | β-isoforms | 1 |
| 1051 | β2-selectivity | 1 |
| 1052 | δta | 1 |
| 1053 | π-activation | 1 |
| 1054 | “pathological | 1 |
| 1055 | ∆acq | 1 |
| 1056 | ∼3-orders | 1 |
| 1057 | ≥208 | 1 |
| 1058 | ≥6-months | 1 |
| 1 | '1:2 | 1 |
| 2 | 'coalescence | 1 |
| 3 | 'doubling | 1 |
| 4 | 'ease | 4 |
| 5 | 'extraction | 1 |
| 6 | 'jadu | 1 |
| 7 | 'localisation | 1 |
| 8 | 'perceptions | 1 |
| 9 | 'reinforcement | 1 |
| 10 | 'representations | 1 |
| 11 | 'stuffy | 1 |
| 12 | 'yakkan | 1 |
| 13 | -604c/1192a | 1 |
| 14 | -benefit | 1 |
| 15 | -diameter | 2 |
| 16 | -lf | 2 |
| 17 | -sialylation | 1 |
| 18 | 0.17-fold | 1 |
| 19 | 0.24±0.04mg | 1 |
| 20 | 0.500mg | 1 |
| 21 | 0.65g/100ml | 1 |
| 22 | 0.6g/l | 1 |
| 23 | 0.6mg/kg | 1 |
| 24 | 0.7g/l | 1 |
| 25 | 0.8-1.5mg/kg | 1 |
| 26 | 09/2006 | 1 |
| 27 | 1,1,1,3,3,3 | 1 |
| 28 | 1,3,4-thiadiazolium- | 1 |
| 29 | 1,4-additions | 1 |
| 30 | 1-nh | 1 |
| 31 | 1.0pj/a | 1 |
| 32 | 1.13±1.22 | 1 |
| 33 | 1.2.6 | 1 |
| 34 | 1.5h/d | 2 |
| 35 | 1.9ng | 1 |
| 36 | 1000s | 2 |
| 37 | 105.61tons | 1 |
| 38 | 11-hydroxy-nbp | 2 |
| 39 | 11-nor- | 1 |
| 40 | 110,931 | 1 |
| 41 | 11193c/c | 3 |
| 42 | 1134khz | 1 |
| 43 | 126+/-10/75+/-7mmhg | 1 |
| 44 | 135° | 13 |
| 45 | 14-3-3a | 1 |
| 46 | 140.3±46.3 | 1 |
| 47 | 14u/mg | 1 |
| 48 | 153+21 | 1 |
| 49 | 15nm | 1 |
| 50 | 16gpa | 1 |
| 51 | 17-s | 1 |
| 52 | 183-bp | 1 |
| 53 | 19,316 | 1 |
| 54 | 19-methyl | 1 |
| 55 | 192-198 | 1 |
| 56 | 196.69 | 1 |
| 57 | 1cc | 1 |
| 58 | 2'-ome-4'-selenorna | 1 |
| 59 | 2,3-o-disulfate-d-galactose | 1 |
| 60 | 2,6-xylidine | 1 |
| 61 | 2-methyl-2,3-butanediol | 3 |
| 62 | 2-oxadiazole-substituted | 1 |
| 63 | 2000hz | 1 |
| 64 | 2002/'03 | 1 |
| 65 | 21-monosulfates | 1 |
| 66 | 21.95+/-6.79 | 1 |
| 67 | 216-221 | 1 |
| 68 | 22.5μg | 1 |
| 69 | 25.3g/l | 1 |
| 70 | 253-264 | 2 |
| 71 | 26±4.4 | 1 |
| 72 | 27.55 | 1 |
| 73 | 272.1 | 1 |
| 74 | 28,849- | 1 |
| 75 | 283.5μg | 1 |
| 76 | 29.1+/-0.8g | 1 |
| 77 | 3'-c-methyl-β-d-allopyranonucleosides | 1 |
| 78 | 3'-fragments | 1 |
| 79 | 3'-phosphoramidites | 1 |
| 80 | 3,341 | 1 |
| 81 | 3,4'-substitution | 1 |
| 82 | 3,5-diethynylpyridine | 2 |
| 83 | 3,5-dihydroxybenzoate | 2 |
| 84 | 3-amidopiperidines | 1 |
| 85 | 3-chlorobiphenyl | 1 |
| 86 | 3-mercapto-1,2,4-4h-triazole | 1 |
| 87 | 3-o-monoacetylation | 2 |
| 88 | 3-positions | 3 |
| 89 | 3.24+/-0.28 | 1 |
| 90 | 30.12.2012 | 1 |
| 91 | 30/94 | 1 |
| 92 | 300-1800μg/g | 1 |
| 93 | 31/05 | 1 |
| 94 | 350pg/ml | 1 |
| 95 | 3=duality | 1 |
| 96 | 3h-cholesterol | 4 |
| 97 | 4'-selenoguanosine | 1 |
| 98 | 4,9-isomers | 1 |
| 99 | 4,949 | 1 |
| 100 | 4-bispeb | 5 |
| 101 | 4-chloropyridine | 1 |
| 102 | 400µl | 1 |
| 103 | 40km | 1 |
| 104 | 414.15 | 1 |
| 105 | 4140.3 | 1 |
| 106 | 42,694 | 1 |
| 107 | 461-479 | 2 |
| 108 | 4h-pyrans | 4 |
| 109 | 5-o-positions | 1 |
| 110 | 5-positions | 6 |
| 111 | 5.0mg | 1 |
| 112 | 5.77-5.93 | 1 |
| 113 | 5/2010 | 1 |
| 114 | 50-weeks | 1 |
| 115 | 53164.84 | 1 |
| 116 | 553.7415mg/kg | 2 |
| 117 | 568mg | 1 |
| 118 | 5779 | 1 |
| 119 | 580°c | 1 |
| 120 | 5ht-uptake | 5 |
| 121 | 6-positions | 3 |
| 122 | 65gy | 1 |
| 123 | 6b11ab2 | 1 |
| 124 | 7-positions | 4 |
| 125 | 720.91 | 1 |
| 126 | 75-d | 1 |
| 127 | 7t3 | 1 |
| 128 | 7years-181 | 1 |
| 129 | 8'-positions | 1 |
| 130 | 8-o-acetyl-sm | 4 |
| 131 | 85.36° | 1 |
| 132 | 9'-positions | 1 |
| 133 | 9-positions | 1 |
| 134 | 9days | 1 |
| 135 | a-bonding | 1 |
| 136 | a2059 | 2 |
| 137 | a53t-mutation | 1 |
| 138 | absenteeism.data | 1 |
| 139 | acceptabililty | 1 |
| 140 | acetylspiramycin | 1 |
| 141 | acquisition/retention | 1 |
| 142 | actionability | 1 |
| 143 | actitest | 3 |
| 144 | ad41 | 1 |
| 145 | adamussium | 1 |
| 146 | addictiveness | 11 |
| 147 | addition/protonolysis | 1 |
| 148 | adolescents.because | 1 |
| 149 | adverse-events | 5 |
| 150 | affordability | 98 |
| 151 | after-study | 1 |
| 152 | after-test | 1 |
| 153 | ager-3 | 1 |
| 154 | air-cooling | 2 |
| 155 | al7cr | 2 |
| 156 | ala333 | 1 |
| 157 | ala387 | 1 |
| 158 | alkali-extractability | 1 |
| 159 | alooh | 1 |
| 160 | alsо | 1 |
| 161 | ameliorability | 1 |
| 162 | aminodarone | 1 |
| 163 | anisodus | 1 |
| 164 | anlagebedingter | 1 |
| 165 | anti-conformations | 1 |
| 166 | anti-geometry | 1 |
| 167 | anti-p504s | 1 |
| 168 | antibiotype | 4 |
| 169 | anticardiolipins | 1 |
| 170 | antimicrobial-performance | 1 |
| 171 | antiogenesis | 1 |
| 172 | apico | 4 |
| 173 | apo-a4 | 3 |
| 174 | ara-supplementation | 1 |
| 175 | arabic-dominant | 1 |
| 176 | ascensia® | 2 |
| 177 | asp104 | 1 |
| 178 | asp114 | 1 |
| 179 | asp145 | 3 |
| 180 | asp156 | 1 |
| 181 | associativity | 2 |
| 182 | astacin-like | 1 |
| 183 | at2-receptors | 2 |
| 184 | auc0-168h/0-336h | 1 |
| 185 | auc0infinity | 2 |
| 186 | auct-∞ | 3 |
| 187 | autecology | 1 |
| 188 | autoreproduction | 1 |
| 189 | avoidability | 1 |
| 190 | axel | 1 |
| 191 | b-19 | 4 |
| 192 | b16arg | 5 |
| 193 | bactrin | 1 |
| 194 | baicelin | 1 |
| 195 | balm-mint | 1 |
| 196 | bapwv/caix | 1 |
| 197 | basc2o4 | 1 |
| 198 | bastions | 1 |
| 199 | bax/bcl | 1 |
| 200 | baxk | 1 |
| 201 | beamformers | 2 |
| 202 | bedclothes | 2 |
| 203 | below-expected-levels | 1 |
| 204 | beta-epimers | 1 |
| 205 | bfmd | 1 |
| 206 | bilaterality | 9 |
| 207 | bio-prospecting | 2 |
| 208 | bio-sources | 1 |
| 209 | bio-tolerance | 1 |
| 210 | biological/quality | 1 |
| 211 | biopiracy | 3 |
| 212 | bioregulation | 1 |
| 213 | bis-hydrazones | 1 |
| 214 | bj/291/09 | 1 |
| 215 | björn | 1 |
| 216 | blandm | 1 |
| 217 | blaoxa-10 | 3 |
| 218 | block-copolymerization | 1 |
| 219 | blowdown | 1 |
| 220 | brahman-angus | 4 |
| 221 | bribery | 2 |
| 222 | buchanania | 1 |
| 223 | byname | 1 |
| 224 | c-ch3 | 1 |
| 225 | c-levels | 2 |
| 226 | c-terminals | 3 |
| 227 | c-termini | 17 |
| 228 | c.glaucophylla | 2 |
| 229 | c15-acetylenic | 1 |
| 230 | c= | 2 |
| 231 | c=2317+/-146 | 1 |
| 232 | cahsp18 | 2 |
| 233 | capillin | 2 |
| 234 | carbonil/mg | 1 |
| 235 | cardio-selectivity | 1 |
| 236 | carl-friedrich | 1 |
| 237 | catguts | 1 |
| 238 | ccl8 | 2 |
| 239 | cd16/ | 1 |
| 240 | cd4cd25 | 2 |
| 241 | cdc2-tyr15 | 1 |
| 242 | cdia | 1 |
| 243 | ce9afr | 3 |
| 244 | cefepime/tazobactam | 2 |
| 245 | cellulites | 3 |
| 246 | centricities | 1 |
| 247 | cf3-dps | 3 |
| 248 | cgi-seve | 1 |
| 249 | ch3-substituted | 1 |
| 250 | ch3mgbr | 1 |
| 251 | ch4/h2-rich | 1 |
| 252 | chaetotaxy | 2 |
| 253 | chanesar | 4 |
| 254 | chirurgia | 1 |
| 255 | chloraemia | 1 |
| 256 | chloroform-fractions | 1 |
| 257 | chlorphenoxamine | 1 |
| 258 | chon | 1 |
| 259 | choreography | 1 |
| 260 | cirrhoses | 1 |
| 261 | client-centeredness | 1 |
| 262 | clinico-pathomorphology | 1 |
| 263 | clonogenesis | 1 |
| 264 | clpx | 2 |
| 265 | clysterizing | 1 |
| 266 | co-linearity | 1 |
| 267 | coaddition | 1 |
| 268 | coadministriation | 1 |
| 269 | codas-verapamil | 1 |
| 270 | coevaporation | 1 |
| 271 | cofounder | 1 |
| 272 | coisolation | 1 |
| 273 | cold-tolerances | 1 |
| 274 | cologarithm | 1 |
| 275 | colony-levels | 1 |
| 276 | community-levels | 1 |
| 277 | competitive-uncompetitive | 1 |
| 278 | comprehensibility | 18 |
| 279 | concealment.most | 1 |
| 280 | conidiomata | 1 |
| 281 | cons | 247 |
| 282 | conservatories | 3 |
| 283 | contamination/estimation | 1 |
| 284 | contras | 1 |
| 285 | control.none | 1 |
| 286 | contrykal | 3 |
| 287 | corneal® | 1 |
| 288 | corporació | 1 |
| 289 | corrosion-resistance | 1 |
| 290 | coryphaei | 1 |
| 291 | cost-effectivenesss | 1 |
| 292 | cost-effictveness | 1 |
| 293 | cost/lyg | 1 |
| 294 | craterispermum | 1 |
| 295 | creutzfeldt | 1 |
| 296 | critical-reflection | 1 |
| 297 | crp-predictors | 1 |
| 298 | crr1 | 3 |
| 299 | cryo-stress | 1 |
| 300 | cryptocoryne | 1 |
| 301 | cslh1 | 4 |
| 302 | cyp4a10 | 1 |
| 303 | cyth1-4 | 1 |
| 304 | cytotoxicicty | 1 |
| 305 | cytotoxictiy | 1 |
| 306 | da/dtmax | 3 |
| 307 | dbt2 | 5 |
| 308 | dcw1 | 1 |
| 309 | de-organization | 1 |
| 310 | deaurative | 1 |
| 311 | decabdes | 1 |
| 312 | dedicator | 1 |
| 313 | deemphasization | 1 |
| 314 | defattening | 1 |
| 315 | deferred/adjuvant | 1 |
| 316 | dehydroepiandrosterone/pregnenolone | 2 |
| 317 | delayers | 1 |
| 318 | delphinium | 1 |
| 319 | demerits | 12 |
| 320 | denticity | 1 |
| 321 | deois | 1 |
| 322 | deolindo | 1 |
| 323 | dequenching | 1 |
| 324 | described-mainly | 1 |
| 325 | desulfurylation | 1 |
| 326 | detorquing | 1 |
| 327 | detyrosination | 2 |
| 328 | development/university | 1 |
| 329 | diabetogenicity | 6 |
| 330 | diauc | 1 |
| 331 | diazepam.meta-analysis | 1 |
| 332 | dichotomitin | 1 |
| 333 | digalactosyl-diglycerides | 1 |
| 334 | dihydralazin | 1 |
| 335 | dil-labeled | 1 |
| 336 | dis-adoption | 1 |
| 337 | disadvantages | 915 |
| 338 | discomplexation | 1 |
| 339 | disempowerment | 2 |
| 340 | displacement/folding | 1 |
| 341 | displacement/neutralisation | 1 |
| 342 | disposes | 1 |
| 343 | distal-halves | 1 |
| 344 | distance-to-water | 2 |
| 345 | distichamine | 3 |
| 346 | distillates | 2 |
| 347 | distributionn | 1 |
| 348 | distributors | 24 |
| 349 | doffing | 3 |
| 350 | don-upregulation | 1 |
| 351 | donja | 2 |
| 352 | dose-comparisons | 1 |
| 353 | downstrokes | 1 |
| 354 | dredging-meridian | 3 |
| 355 | dsm-iv-classification | 1 |
| 356 | duration-time | 1 |
| 357 | dys-function | 1 |
| 358 | dyspepsia/abdominal | 1 |
| 359 | e-indexes | 1 |
| 360 | ea-dt | 1 |
| 361 | ec90s | 1 |
| 362 | eco-toxicity | 2 |
| 363 | edibility | 10 |
| 364 | effect/side-effect | 1 |
| 365 | elecctroacupuncture | 1 |
| 366 | eliminators | 1 |
| 367 | ellipro | 1 |
| 368 | eloquence | 1 |
| 369 | embase.date | 2 |
| 370 | emilienne-rose | 1 |
| 371 | enablers | 26 |
| 372 | endosonography/doppler | 1 |
| 373 | endurance-is | 1 |
| 374 | energy-depletion | 1 |
| 375 | energy-domains | 1 |
| 376 | entercocci | 1 |
| 377 | eohsp70 | 7 |
| 378 | ep-cp2 | 1 |
| 379 | epidemiology-bips | 1 |
| 380 | epuraea | 1 |
| 381 | erl1576 | 1 |
| 382 | errhysis | 1 |
| 383 | erythocytes | 2 |
| 384 | erythroplakia | 7 |
| 385 | esms | 1 |
| 386 | esxgms | 3 |
| 387 | et-rb | 1 |
| 388 | ethanol-responsive | 1 |
| 389 | ethicity | 1 |
| 390 | eumorphism | 1 |
| 391 | eveness | 1 |
| 392 | everusers | 1 |
| 393 | exaceration | 1 |
| 394 | exclusivity | 79 |
| 395 | exercise'.date | 1 |
| 396 | exobidentate | 1 |
| 397 | expulsation | 2 |
| 398 | extra-value | 1 |
| 399 | exurbs | 1 |
| 400 | facilitation/co-ordination | 1 |
| 401 | faithfulness | 5 |
| 402 | falsehood | 1 |
| 403 | fantastyczne | 1 |
| 404 | farm-numbers | 1 |
| 405 | fatigue/loss | 1 |
| 406 | fe-bearing | 1 |
| 407 | fe3c | 1 |
| 408 | feasibility-of-use | 1 |
| 409 | fentanyl-dexmedetomidine | 2 |
| 410 | ff+sr | 3 |
| 411 | filtrates/antibiotics | 1 |
| 412 | flabbiness | 1 |
| 413 | fosc2 | 1 |
| 414 | foxo3a-phosphorylation | 1 |
| 415 | fracture-dislocations | 1 |
| 416 | fracure | 1 |
| 417 | free-exciton | 1 |
| 418 | freedom/rights | 1 |
| 419 | fruit/berries/juice | 2 |
| 420 | fsmm26 | 2 |
| 421 | g-browser | 1 |
| 422 | galiomycin | 1 |
| 423 | gangrenes | 2 |
| 424 | gansull-62110372 | 1 |
| 425 | gastro-sparing | 1 |
| 426 | gem/oxaliplatin | 2 |
| 427 | geneticization | 1 |
| 428 | gfp-tagging | 1 |
| 429 | ghareghoroot | 1 |
| 430 | giblets | 2 |
| 431 | gl-ex | 2 |
| 432 | glicidic | 1 |
| 433 | glu232 | 1 |
| 434 | glu371 | 1 |
| 435 | glu59 | 1 |
| 436 | glutaminolysis | 5 |
| 437 | glücklich | 1 |
| 438 | gnrh-administered | 1 |
| 439 | gog-0172 | 1 |
| 440 | gpx-activity | 3 |
| 441 | graphing | 1 |
| 442 | grbio | 1 |
| 443 | grimontia | 1 |
| 444 | gsk1016790a | 4 |
| 445 | gstp-1 | 4 |
| 446 | gueltas | 1 |
| 447 | gv2 | 1 |
| 448 | hacat-2 | 1 |
| 449 | hadd | 3 |
| 450 | haemostasia | 1 |
| 451 | handcuff | 1 |
| 452 | hap14 | 1 |
| 453 | haploglossa | 1 |
| 454 | harms | 2,056 |
| 455 | hba2- | 1 |
| 456 | heat-inhibition | 1 |
| 457 | heat-patterns | 2 |
| 458 | heliconema | 1 |
| 459 | hetero-dimerization | 1 |
| 460 | hetero-fret | 1 |
| 461 | heterophilia | 3 |
| 462 | hev-4 | 1 |
| 463 | high-tertiles | 1 |
| 464 | hindbrains | 1 |
| 465 | history/evidence | 2 |
| 466 | hoarsness | 1 |
| 467 | holzbach | 2 |
| 468 | homa-ia | 1 |
| 469 | homa-ir-index | 1 |
| 470 | homobenization | 1 |
| 471 | homol-d | 1 |
| 472 | homozygotization | 1 |
| 473 | hospital-length | 1 |
| 474 | hsp20.8 | 3 |
| 475 | hsp2667 | 3 |
| 476 | hsp50 | 2 |
| 477 | hsp90/grα | 2 |
| 478 | hspb5/hspb6 | 3 |
| 479 | hsv-2-dna | 1 |
| 480 | hurubayashi | 1 |
| 481 | hybanthus | 1 |
| 482 | hydration-dependence | 1 |
| 483 | hydrochlorothiazide/amiloride | 1 |
| 484 | hyermagnesuria | 1 |
| 485 | hyper-activity | 1 |
| 486 | hyper-production | 1 |
| 487 | hyperadhesivity | 1 |
| 488 | hypermotility | 2 |
| 489 | hypertrophy/degeneration | 1 |
| 490 | hypoplastia | 1 |
| 491 | hyporreflexie | 2 |
| 492 | iconography | 3 |
| 493 | id-test | 1 |
| 494 | identifcation | 1 |
| 495 | ifn-γ-treatment | 1 |
| 496 | igκ | 2 |
| 497 | il-1β1 | 1 |
| 498 | il-6-ar | 3 |
| 499 | ile932 | 2 |
| 500 | il‑β | 1 |
| 501 | imb-15 | 3 |
| 502 | immuno-probing | 1 |
| 503 | immunome | 1 |
| 504 | immuphenotypic | 1 |
| 505 | inaptness | 1 |
| 506 | inbalance | 1 |
| 507 | incidence/duration | 1 |
| 508 | inconvenience | 155 |
| 509 | indium-promoted | 1 |
| 510 | infant.models | 1 |
| 511 | infantilization | 1 |
| 512 | influx/efflux | 1 |
| 513 | infracommunities | 1 |
| 514 | innocuousness | 3 |
| 515 | instigator | 2 |
| 516 | inter-dependency | 3 |
| 517 | interanalysis | 1 |
| 518 | interrelatedness | 6 |
| 519 | intra-breath | 1 |
| 520 | intra-reproducibility | 1 |
| 521 | investigator-rating | 1 |
| 522 | isaba14 | 1 |
| 523 | islampur | 2 |
| 524 | isolation/purification | 1 |
| 525 | isoprocarb | 3 |
| 526 | jeff | 1 |
| 527 | jinghou | 1 |
| 528 | joyeuxiella | 1 |
| 529 | jtc-801 | 2 |
| 530 | judications | 1 |
| 531 | juicing | 1 |
| 532 | jungner | 3 |
| 533 | kaishihen | 1 |
| 534 | kanton | 1 |
| 535 | kappa-carrageenan | 3 |
| 536 | katabi | 1 |
| 537 | kca2.2 | 1 |
| 538 | kinetics/duration | 1 |
| 539 | kotalagenin | 1 |
| 540 | kpl-4 | 1 |
| 541 | ktcd15 | 1 |
| 542 | kv1.6 | 3 |
| 543 | l-erythro- | 1 |
| 544 | l-monomenthyl | 1 |
| 545 | l289 | 1 |
| 546 | l5s1 | 1 |
| 547 | lasting-time | 2 |
| 548 | laureliopsis | 2 |
| 549 | lc90s | 2 |
| 550 | ldh-b | 2 |
| 551 | ldl-subfraction | 1 |
| 552 | lengths/heights | 1 |
| 553 | leucojum | 1 |
| 554 | lheidli | 1 |
| 555 | libido/potency | 1 |
| 556 | licaria | 1 |
| 557 | lifestyle-factors | 2 |
| 558 | limnocythere | 1 |
| 559 | lipoprotein-metabolism | 1 |
| 560 | livertox | 1 |
| 561 | lomflox | 1 |
| 562 | lt90s | 2 |
| 563 | lys331 | 1 |
| 564 | ma-cii | 3 |
| 565 | macrocirculation | 9 |
| 566 | madhav | 1 |
| 567 | maeil4 | 2 |
| 568 | magnetoelasticity | 1 |
| 569 | maianthemum | 1 |
| 570 | maintanence | 1 |
| 571 | maintenance/reverberation | 1 |
| 572 | majhi | 3 |
| 573 | makhzan | 2 |
| 574 | malazzesia | 1 |
| 575 | masf | 1 |
| 576 | mast-6 | 2 |
| 577 | mcgill-quality | 1 |
| 578 | mdkrps | 1 |
| 579 | mechanomyography | 3 |
| 580 | medline.date | 2 |
| 581 | meltability | 3 |
| 582 | merchandizing | 1 |
| 583 | meshasringi | 1 |
| 584 | mesocotyls | 1 |
| 585 | meta-rr | 1 |
| 586 | metastatisation | 1 |
| 587 | metohi | 1 |
| 588 | metohija | 3 |
| 589 | micro-location | 1 |
| 590 | microbody | 3 |
| 591 | microcavitation | 1 |
| 592 | microfibrosis | 1 |
| 593 | micromegakaryocyte | 1 |
| 594 | micron-flowers | 2 |
| 595 | micro‑architecture | 3 |
| 596 | mid-segments | 5 |
| 597 | mid-term-follow-up | 1 |
| 598 | midazolam.assessment | 1 |
| 599 | millimeter/degree | 1 |
| 600 | minimizing-by | 1 |
| 601 | mir-193b* | 3 |
| 602 | mirror-words | 4 |
| 603 | misinsertion | 1 |
| 604 | mispecification | 1 |
| 605 | mixing/absorption | 1 |
| 606 | monotetrahydropyranylation | 1 |
| 607 | mortalitysahsubarachnoid | 1 |
| 608 | moussonia | 1 |
| 609 | mpqx | 4 |
| 610 | mri-lvh | 2 |
| 611 | mrxs | 1 |
| 612 | ms-self | 1 |
| 613 | mtx.harmsthere | 1 |
| 614 | multi-horseradish | 1 |
| 615 | multidisciplinarity | 1 |
| 616 | multiplicity/redundancy | 1 |
| 617 | mutagenecity | 1 |
| 618 | n-protection | 1 |
| 619 | nam26-15a | 2 |
| 620 | nano-scales | 2 |
| 621 | nature/severity | 1 |
| 622 | near-normalisation | 1 |
| 623 | neo-ι-carrahexaose | 1 |
| 624 | neobuccinum | 1 |
| 625 | neurofacilitation | 3 |
| 626 | neurotolerability | 1 |
| 627 | news-recipients | 4 |
| 628 | nhp-pain | 1 |
| 629 | nickeltitanium | 1 |
| 630 | nicotine-both | 1 |
| 631 | nido-shaped | 1 |
| 632 | nimodipine-method | 1 |
| 633 | nitzschia | 2 |
| 634 | nmh-th-4 | 1 |
| 635 | non-adoption | 1 |
| 636 | non-cap-lrti | 4 |
| 637 | non-her2-genes | 2 |
| 638 | non-pfc | 1 |
| 639 | non-reaming | 1 |
| 640 | non-receivers | 3 |
| 641 | non-requirement | 1 |
| 642 | non-resurfacing | 1 |
| 643 | non-shedders | 1 |
| 644 | non-snorers | 1 |
| 645 | non-specificity | 7 |
| 646 | non-spvc | 2 |
| 647 | noninternalization | 2 |
| 648 | nonmembers | 1 |
| 649 | nonprostitutes | 1 |
| 650 | nonrecyclability | 1 |
| 651 | nonrisks | 1 |
| 652 | nonstandardisation | 1 |
| 653 | nontransfer | 2 |
| 654 | nonwelders | 1 |
| 655 | notozulia | 1 |
| 656 | nucleustide | 1 |
| 657 | number/severity | 1 |
| 658 | nwib-05 | 1 |
| 659 | nxk6-1 | 1 |
| 660 | ny-198 | 2 |
| 661 | n¹-position | 1 |
| 662 | o-n-acetyl | 1 |
| 663 | octasonol | 2 |
| 664 | odd-number | 1 |
| 665 | ogl | 2 |
| 666 | oligo-glycosides | 1 |
| 667 | olkin | 4 |
| 668 | oncoba | 1 |
| 669 | optical-spatial | 1 |
| 670 | oralcefalosporins | 1 |
| 671 | orf57 | 2 |
| 672 | organification | 1 |
| 673 | ortho-metallation | 1 |
| 674 | ortho-orientations | 1 |
| 675 | osteo-fixation | 1 |
| 676 | ostheosynthesis | 1 |
| 677 | other-ratings | 1 |
| 678 | ovafolinin | 1 |
| 679 | ovarian-hormone-dependence | 1 |
| 680 | over-exploitation | 5 |
| 681 | over-scheduling | 1 |
| 682 | overadministration | 1 |
| 683 | overdevelopment | 1 |
| 684 | overexertion | 7 |
| 685 | overgeneralization | 7 |
| 686 | overinterpretation | 1 |
| 687 | overtitration | 1 |
| 688 | p-30 | 1 |
| 689 | p-conditions | 1 |
| 690 | p-duration | 1 |
| 691 | p-nkcc2 | 1 |
| 692 | p-ratios | 5 |
| 693 | pace-mapping | 1 |
| 694 | papulo-nodular | 1 |
| 695 | papulovesicle | 1 |
| 696 | para-positions | 3 |
| 697 | paracolobactrum | 1 |
| 698 | paraplegia/hemiplegia | 4 |
| 699 | parcel | 11 |
| 700 | parcial | 1 |
| 701 | paris.participants | 1 |
| 702 | partial-thromboplastin-time | 1 |
| 703 | pathopsychology | 1 |
| 704 | pblood | 1 |
| 705 | pcsk7 | 1 |
| 706 | pectinifrons | 1 |
| 707 | pedobarography | 1 |
| 708 | peg-ifn/rbv-therapy | 1 |
| 709 | pellet-pressure | 1 |
| 710 | pentaruthenium | 1 |
| 711 | peptidyl-glycine-α-amidating | 1 |
| 712 | perceptions/opinions | 1 |
| 713 | perio- | 1 |
| 714 | peritoneography | 1 |
| 715 | permissivity | 1 |
| 716 | pertinency | 1 |
| 717 | pet28a- | 1 |
| 718 | petioles | 8 |
| 719 | ph10.5 | 1 |
| 720 | pharmacodynamics | 807 |
| 721 | phenylosazones | 1 |
| 722 | pherthima | 1 |
| 723 | phleboscleroobliteration | 1 |
| 724 | phlebotomists | 1 |
| 725 | phospho-pka | 1 |
| 726 | phosphorodiamidates | 1 |
| 727 | physconia | 1 |
| 728 | pi828 | 2 |
| 729 | pid3 | 2 |
| 730 | pimr | 1 |
| 731 | piperidine-3-ol-derived | 1 |
| 732 | piperidinyl-3,4- | 1 |
| 733 | pitangus | 1 |
| 734 | placebo+folfiri | 1 |
| 735 | placebolike | 1 |
| 736 | placement/removal | 2 |
| 737 | plva | 1 |
| 738 | pneumocysts | 1 |
| 739 | pneumonia/sepsis | 1 |
| 740 | polyglobulia | 1 |
| 741 | polymyxine-b | 1 |
| 742 | polypharmacology | 8 |
| 743 | polysphaeridium | 1 |
| 744 | possbilities | 1 |
| 745 | post-40-minutes | 1 |
| 746 | post-c | 2 |
| 747 | post-graphenization | 1 |
| 748 | post-measurements | 2 |
| 749 | post-measures | 4 |
| 750 | post-pe | 1 |
| 751 | postassesment | 1 |
| 752 | postdisinfection | 1 |
| 753 | postfasting | 1 |
| 754 | postfixation | 1 |
| 755 | posthydration | 5 |
| 756 | postintroduction | 2 |
| 757 | posttraumatischer | 1 |
| 758 | praxias | 1 |
| 759 | pre-2 | 2 |
| 760 | precompensation | 1 |
| 761 | prescribability | 2 |
| 762 | prescribing/titration | 1 |
| 763 | primer-dependent | 1 |
| 764 | pro142 | 1 |
| 765 | probtec | 2 |
| 766 | process-quality | 1 |
| 767 | pronominal | 1 |
| 768 | prostaglandin-induction | 1 |
| 769 | protein-retinoblastoma-binding | 1 |
| 770 | protégés | 1 |
| 771 | provenience | 2 |
| 772 | pseudo-elasticity | 1 |
| 773 | pseudo-outbreaks | 1 |
| 774 | pseudocroup | 1 |
| 775 | pseudopositivity | 1 |
| 776 | psychosomatics | 5 |
| 777 | psychosurgery | 1 |
| 778 | psychrotrophs | 1 |
| 779 | pten-negativity | 1 |
| 780 | pteridine-containing | 1 |
| 781 | puericulture | 1 |
| 782 | pulsellum | 1 |
| 783 | pyruvate/ | 1 |
| 784 | q137 | 1 |
| 785 | qualty | 1 |
| 786 | r-104 | 1 |
| 787 | r545 | 6 |
| 788 | r=17 | 1 |
| 789 | radixes | 1 |
| 790 | rafflesia | 1 |
| 791 | ralitza | 1 |
| 792 | rar-alpha | 1 |
| 793 | rbc-amoxicillin-nitroimidazole | 1 |
| 794 | rbmhsp-70 | 2 |
| 795 | re-acceleration | 1 |
| 796 | re-internalization | 1 |
| 797 | re-living | 1 |
| 798 | reactogenicity | 298 |
| 799 | reappraisals | 5 |
| 800 | reassurance-seeking | 4 |
| 801 | recentness | 1 |
| 802 | receptaculum | 1 |
| 803 | recyclability | 10 |
| 804 | reduction/discontinuance | 1 |
| 805 | reenforcement | 1 |
| 806 | refolding/degradation | 1 |
| 807 | regioslectivity | 1 |
| 808 | regressiveness | 1 |
| 809 | reinvigoration | 1 |
| 810 | remission/near-remission | 1 |
| 811 | remission/resolution | 1 |
| 812 | repack | 1 |
| 813 | repositioning/preparation | 1 |
| 814 | reprimo | 2 |
| 815 | rerinse | 1 |
| 816 | resistant-strains | 1 |
| 817 | resolidification | 3 |
| 818 | resoption | 1 |
| 819 | resubmersion | 1 |
| 820 | retranslocation | 4 |
| 821 | retrogradation | 11 |
| 822 | reusability | 22 |
| 823 | rhadinopsylla | 1 |
| 824 | rifampin-type | 1 |
| 825 | robins-mark-newey | 1 |
| 826 | rs12767583 | 1 |
| 827 | rs2298383 | 1 |
| 828 | rs2427824 | 1 |
| 829 | rs4648261 | 1 |
| 830 | rs4953023 | 2 |
| 831 | rsahr2 | 1 |
| 832 | rsreg | 1 |
| 833 | ruggedness | 5 |
| 834 | rupivacaine | 1 |
| 835 | rv-em/am | 1 |
| 836 | rvsv-hsp70 | 1 |
| 837 | rxralpha | 2 |
| 838 | s-enantiomers | 14 |
| 839 | s549 | 1 |
| 840 | saccule | 1 |
| 841 | safeties | 9 |
| 842 | safetiness | 1 |
| 843 | safety/ae | 1 |
| 844 | safety/reactogenicity | 5 |
| 845 | safety/toxicity | 7 |
| 846 | safetyness | 1 |
| 847 | saltness | 1 |
| 848 | sarong | 1 |
| 849 | satisfaction-with-hospital | 2 |
| 850 | sawacillin | 1 |
| 851 | sbe4 | 1 |
| 852 | scientificalness | 3 |
| 853 | scutia | 1 |
| 854 | second-tur | 2 |
| 855 | seed-grain | 1 |
| 856 | seed-targeting | 2 |
| 857 | self-annealing | 1 |
| 858 | self-checking | 1 |
| 859 | self-cultivation | 1 |
| 860 | self-dosing | 1 |
| 861 | self-fulfillment | 2 |
| 862 | self-rationalisations | 1 |
| 863 | semi-quantity | 1 |
| 864 | septal-em/am | 1 |
| 865 | sequlae | 1 |
| 866 | ser7 | 5 |
| 867 | ser80leu | 1 |
| 868 | ser864 | 1 |
| 869 | sert-i612q | 1 |
| 870 | sert-p601a/g602a | 2 |
| 871 | sga-preterm | 1 |
| 872 | shaanxi10-h0091 | 1 |
| 873 | shangshi | 1 |
| 874 | shareholder | 1 |
| 875 | short-courses | 2 |
| 876 | short-term.there | 1 |
| 877 | sickness-impact | 1 |
| 878 | side-effect | 489 |
| 879 | sievings | 1 |
| 880 | sihsp19.6 | 3 |
| 881 | single-blinding | 3 |
| 882 | sip-1 | 1 |
| 883 | sister.marcus | 1 |
| 884 | skm2 | 2 |
| 885 | slackness | 1 |
| 886 | slave-owning | 1 |
| 887 | slc7a5 | 1 |
| 888 | slhsp20.8 | 1 |
| 889 | slr1 | 1 |
| 890 | slu24a | 2 |
| 891 | sm+dm | 1 |
| 892 | smad-7 | 1 |
| 893 | smd2 | 3 |
| 894 | smilacaceae | 1 |
| 895 | solvation/desolvation | 1 |
| 896 | sophus | 1 |
| 897 | soread | 1 |
| 898 | sortic | 1 |
| 899 | soul | 35 |
| 900 | spallations | 1 |
| 901 | spermine-nonoate | 1 |
| 902 | sphenodesmus | 1 |
| 903 | spirituality.results | 1 |
| 904 | spo2nellcor | 1 |
| 905 | spore-load | 1 |
| 906 | sportsmanship | 2 |
| 907 | spraining | 1 |
| 908 | spreadability | 5 |
| 909 | steatitis | 1 |
| 910 | stem-wood | 1 |
| 911 | stmn3 | 2 |
| 912 | strengths/weaknesses | 1 |
| 913 | suas | 1 |
| 914 | sub-species | 2 |
| 915 | subcoccinella | 1 |
| 916 | subregistries | 1 |
| 917 | subsequent-hfes | 1 |
| 918 | subsequent-lines | 1 |
| 919 | substenosis | 1 |
| 920 | sulphamethomidine | 1 |
| 921 | sum-severity | 1 |
| 922 | super-imposition | 1 |
| 923 | supervision/direction | 1 |
| 924 | supramarginal_r | 1 |
| 925 | sustainment | 8 |
| 926 | sustention | 1 |
| 927 | suvanine | 4 |
| 928 | suvrange | 6 |
| 929 | switching/augmentation | 1 |
| 930 | symphyotrichum | 1 |
| 931 | synclisia | 1 |
| 932 | syncopating | 1 |
| 933 | synopses | 7 |
| 934 | systemization | 1 |
| 935 | sūn | 1 |
| 936 | t-3-mpe | 2 |
| 937 | t-91825 | 1 |
| 938 | t-terminated | 1 |
| 939 | t12-l4 | 1 |
| 940 | t8-sacrum | 5 |
| 941 | tagamyb2 | 1 |
| 942 | tanyu | 1 |
| 943 | tar-staining | 1 |
| 944 | task-dependence | 1 |
| 945 | tatarinow | 1 |
| 946 | teleology | 1 |
| 947 | temenothorax | 1 |
| 948 | temporal-comparison | 1 |
| 949 | tepidimicrobium | 1 |
| 950 | tetraphosphopeptides | 1 |
| 951 | thbe | 1 |
| 952 | the-state | 1 |
| 953 | thermo-electricity | 1 |
| 954 | thickning | 1 |
| 955 | thioesterification | 1 |
| 956 | thorns | 6 |
| 957 | thr473 | 1 |
| 958 | thrombocytopenia.elevation | 1 |
| 959 | throttling | 1 |
| 960 | time-ratio | 1 |
| 961 | time-responses | 2 |
| 962 | time-to-completion | 3 |
| 963 | time-to-deterioration | 1 |
| 964 | time-to-hatching | 1 |
| 965 | tissue-dependency | 1 |
| 966 | tocopherol-to-lipids | 1 |
| 967 | tolerability | 7,958 |
| 968 | tolerability/safety | 7 |
| 969 | tolerabilty | 1 |
| 970 | toleration | 37 |
| 971 | tomentosin | 2 |
| 972 | top4 | 1 |
| 973 | torerability | 1 |
| 974 | torynurus | 1 |
| 975 | touluse | 1 |
| 976 | toxicity-profiles | 1 |
| 977 | tp/rr | 6 |
| 978 | trait-effects | 1 |
| 979 | trans-infection | 1 |
| 980 | trans-junction | 1 |
| 981 | transcatheterimplantation | 1 |
| 982 | transformation/decomposition | 1 |
| 983 | translatability | 11 |
| 984 | treg-dysfunction | 1 |
| 985 | tribonate | 1 |
| 986 | tricellulin | 2 |
| 987 | triglycerides.studies | 1 |
| 988 | type/level | 1 |
| 989 | tyr16 | 1 |
| 990 | tyrasine | 1 |
| 991 | u4/u6 | 1 |
| 992 | ultra-stabilised | 1 |
| 993 | un-folding | 1 |
| 994 | unaffordability | 1 |
| 995 | unavailablility | 1 |
| 996 | under-dose | 1 |
| 997 | under-enhancement | 1 |
| 998 | under-estimates | 7 |
| 999 | underdocumentations | 1 |
| 1000 | underfill | 2 |
| 1001 | underloading | 1 |
| 1002 | underpower | 1 |
| 1003 | underprotection | 1 |
| 1004 | underrepresentations | 1 |
| 1005 | unhomogeneity | 1 |
| 1006 | union-application | 1 |
| 1007 | uration | 1 |
| 1008 | urban-slums | 1 |
| 1009 | uretectomy | 1 |
| 1010 | uretero-vesiconeostomy | 1 |
| 1011 | urine-parameters | 2 |
| 1012 | uv-detection | 1 |
| 1013 | uv/tio2 | 3 |
| 1014 | value/effectiveness | 1 |
| 1015 | venerology | 1 |
| 1016 | verify3d | 1 |
| 1017 | washing-disinfection | 1 |
| 1018 | wcp14 | 1 |
| 1019 | wearability | 4 |
| 1020 | web-rhetoric | 1 |
| 1021 | well-bonded | 1 |
| 1022 | whoqol-breff | 1 |
| 1023 | width/thickness | 1 |
| 1024 | withdrawl | 1 |
| 1025 | wladyslaw | 1 |
| 1026 | wolfhard | 1 |
| 1027 | wonca-quality | 1 |
| 1028 | work-ability | 4 |
| 1029 | work-conservation | 1 |
| 1030 | wrist/hands | 1 |
| 1031 | wysong | 1 |
| 1032 | włodzimierz | 1 |
| 1033 | xianling | 2 |
| 1034 | y-axes | 1 |
| 1035 | ydrogen | 1 |
| 1036 | ym-71213 | 1 |
| 1037 | yy2 | 2 |
| 1038 | z-axes | 2 |
| 1039 | zc-fdps | 1 |
| 1040 | zozhi | 1 |
| 1041 | zygmunt | 1 |
| 1042 | α-internexin | 1 |
| 1043 | α-l-rhamnopyranoside | 1 |
| 1044 | α1β1 | 2 |
| 1045 | α2-subunits | 1 |
| 1046 | β-d-galactopyranoside | 1 |
| 1047 | β-isoforms | 1 |
| 1048 | β-pinenes | 3 |
| 1049 | β2-selectivity | 1 |
| 1050 | δgra= | 2 |
| 1051 | δta | 1 |
| 1052 | νasno2 | 2 |
| 1053 | π-activation | 1 |
| 1054 | “pathological | 1 |
| 1055 | ∆acq | 1 |
| 1056 | ∼3-orders | 1 |
| 1057 | ≥208 | 1 |
| 1058 | ≥6-months | 1 |
| 1 | mir-193b* | 3 |
| 2 | hba2- | 1 |
| 3 | piperidinyl-3,4- | 1 |
| 4 | 28,849- | 1 |
| 5 | pet28a- | 1 |
| 6 | 1,3,4-thiadiazolium- | 1 |
| 7 | perio- | 1 |
| 8 | l-erythro- | 1 |
| 9 | 11-nor- | 1 |
| 10 | cd16/ | 1 |
| 11 | pyruvate/ | 1 |
| 12 | blaoxa-10 | 3 |
| 13 | 5/2010 | 1 |
| 14 | cyp4a10 | 1 |
| 15 | p-30 | 1 |
| 16 | hsp50 | 2 |
| 17 | rbmhsp-70 | 2 |
| 18 | rvsv-hsp70 | 1 |
| 19 | eohsp70 | 7 |
| 20 | nxk6-1 | 1 |
| 21 | sip-1 | 1 |
| 22 | gstp-1 | 4 |
| 23 | 272.1 | 1 |
| 24 | jtc-801 | 2 |
| 25 | 153+21 | 1 |
| 26 | 216-221 | 1 |
| 27 | lys331 | 1 |
| 28 | 110,931 | 1 |
| 29 | 3,341 | 1 |
| 30 | ad41 | 1 |
| 31 | rs4648261 | 1 |
| 32 | glu371 | 1 |
| 33 | 7years-181 | 1 |
| 34 | 720.91 | 1 |
| 35 | shaanxi10-h0091 | 1 |
| 36 | cslh1 | 4 |
| 37 | slr1 | 1 |
| 38 | crr1 | 3 |
| 39 | l5s1 | 1 |
| 40 | dcw1 | 1 |
| 41 | il-1β1 | 1 |
| 42 | α1β1 | 2 |
| 43 | pre-2 | 2 |
| 44 | hacat-2 | 1 |
| 45 | kca2.2 | 1 |
| 46 | 30.12.2012 | 1 |
| 47 | 1.13±1.22 | 1 |
| 48 | glu232 | 1 |
| 49 | ile932 | 2 |
| 50 | pro142 | 1 |
| 51 | gog-0172 | 1 |
| 52 | gansull-62110372 | 1 |
| 53 | '1:2 | 1 |
| 54 | 6b11ab2 | 1 |
| 55 | tagamyb2 | 1 |
| 56 | p-nkcc2 | 1 |
| 57 | fosc2 | 1 |
| 58 | smd2 | 3 |
| 59 | skm2 | 2 |
| 60 | uv/tio2 | 3 |
| 61 | νasno2 | 2 |
| 62 | ep-cp2 | 1 |
| 63 | rsahr2 | 1 |
| 64 | dbt2 | 5 |
| 65 | gv2 | 1 |
| 66 | yy2 | 2 |
| 67 | 1,1,1,3,3,3 | 1 |
| 68 | ager-3 | 1 |
| 69 | 4140.3 | 1 |
| 70 | 140.3±46.3 | 1 |
| 71 | 2002/'03 | 1 |
| 72 | ym-71213 | 1 |
| 73 | rs4953023 | 2 |
| 74 | ala333 | 1 |
| 75 | thr473 | 1 |
| 76 | rs2298383 | 1 |
| 77 | rs12767583 | 1 |
| 78 | 5.77-5.93 | 1 |
| 79 | pid3 | 2 |
| 80 | c-ch3 | 1 |
| 81 | stmn3 | 2 |
| 82 | 7t3 | 1 |
| 83 | cyth1-4 | 1 |
| 84 | nmh-th-4 | 1 |
| 85 | kpl-4 | 1 |
| 86 | hev-4 | 1 |
| 87 | 26±4.4 | 1 |
| 88 | r-104 | 1 |
| 89 | asp104 | 1 |
| 90 | asp114 | 1 |
| 91 | isaba14 | 1 |
| 92 | hap14 | 1 |
| 93 | wcp14 | 1 |
| 94 | rs2427824 | 1 |
| 95 | 253-264 | 2 |
| 96 | ser864 | 1 |
| 97 | 53164.84 | 1 |
| 98 | 30/94 | 1 |
| 99 | 42,694 | 1 |
| 100 | apo-a4 | 3 |
| 101 | sbe4 | 1 |
| 102 | t12-l4 | 1 |
| 103 | maeil4 | 2 |
| 104 | basc2o4 | 1 |
| 105 | top4 | 1 |
| 106 | ph10.5 | 1 |
| 107 | nwib-05 | 1 |
| 108 | 31/05 | 1 |
| 109 | imb-15 | 3 |
| 110 | 414.15 | 1 |
| 111 | ktcd15 | 1 |
| 112 | cdc2-tyr15 | 1 |
| 113 | t-91825 | 1 |
| 114 | cd4cd25 | 2 |
| 115 | asp145 | 3 |
| 116 | r545 | 6 |
| 117 | 27.55 | 1 |
| 118 | slc7a5 | 1 |
| 119 | mast-6 | 2 |
| 120 | kv1.6 | 3 |
| 121 | 1.2.6 | 1 |
| 122 | sihsp19.6 | 3 |
| 123 | 09/2006 | 1 |
| 124 | 19,316 | 1 |
| 125 | tyr16 | 1 |
| 126 | fsmm26 | 2 |
| 127 | c=2317+/-146 | 1 |
| 128 | asp156 | 1 |
| 129 | erl1576 | 1 |
| 130 | hspb5/hspb6 | 3 |
| 131 | u4/u6 | 1 |
| 132 | smad-7 | 1 |
| 133 | r=17 | 1 |
| 134 | q137 | 1 |
| 135 | orf57 | 2 |
| 136 | hsp2667 | 3 |
| 137 | ala387 | 1 |
| 138 | pcsk7 | 1 |
| 139 | ser7 | 5 |
| 140 | hsp20.8 | 3 |
| 141 | slhsp20.8 | 1 |
| 142 | ≥208 | 1 |
| 143 | cahsp18 | 2 |
| 144 | 3.24+/-0.28 | 1 |
| 145 | pi828 | 2 |
| 146 | 192-198 | 1 |
| 147 | ny-198 | 2 |
| 148 | ccl8 | 2 |
| 149 | bj/291/09 | 1 |
| 150 | b-19 | 4 |
| 151 | s549 | 1 |
| 152 | 4,949 | 1 |
| 153 | a2059 | 2 |
| 154 | glu59 | 1 |
| 155 | 196.69 | 1 |
| 156 | 21.95+/-6.79 | 1 |
| 157 | 461-479 | 2 |
| 158 | 5779 | 1 |
| 159 | l289 | 1 |
| 160 | δgra= | 2 |
| 161 | c= | 2 |
| 162 | 1.0pj/a | 1 |
| 163 | gsk1016790a | 4 |
| 164 | sert-p601a/g602a | 2 |
| 165 | -604c/1192a | 1 |
| 166 | 14-3-3a | 1 |
| 167 | slu24a | 2 |
| 168 | nam26-15a | 2 |
| 169 | oncoba | 1 |
| 170 | epuraea | 1 |
| 171 | rar-alpha | 1 |
| 172 | rxralpha | 2 |
| 173 | homa-ia | 1 |
| 174 | cdia | 1 |
| 175 | paraplegia/hemiplegia | 4 |
| 176 | chirurgia | 1 |
| 177 | nitzschia | 2 |
| 178 | erythroplakia | 7 |
| 179 | heterophilia | 3 |
| 180 | polyglobulia | 1 |
| 181 | notozulia | 1 |
| 182 | chloraemia | 1 |
| 183 | buchanania | 1 |
| 184 | physconia | 1 |
| 185 | moussonia | 1 |
| 186 | licaria | 1 |
| 187 | hyermagnesuria | 1 |
| 188 | haemostasia | 1 |
| 189 | rafflesia | 1 |
| 190 | malazzesia | 1 |
| 191 | synclisia | 1 |
| 192 | grimontia | 1 |
| 193 | hypoplastia | 1 |
| 194 | scutia | 1 |
| 195 | metohija | 3 |
| 196 | donja | 2 |
| 197 | phospho-pka | 1 |
| 198 | joyeuxiella | 1 |
| 199 | subcoccinella | 1 |
| 200 | c.glaucophylla | 2 |
| 201 | rhadinopsylla | 1 |
| 202 | heliconema | 1 |
| 203 | pherthima | 1 |
| 204 | hsv-2-dna | 1 |
| 205 | 2'-ome-4'-selenorna | 1 |
| 206 | 16gpa | 1 |
| 207 | haploglossa | 1 |
| 208 | absenteeism.data | 1 |
| 209 | conidiomata | 1 |
| 210 | δta | 1 |
| 211 | plva | 1 |
| 212 | ralitza | 1 |
| 213 | polymyxine-b | 1 |
| 214 | ldh-b | 2 |
| 215 | 4-bispeb | 5 |
| 216 | et-rb | 1 |
| 217 | isoprocarb | 3 |
| 218 | post-c | 2 |
| 219 | 11193c/c | 3 |
| 220 | fe3c | 1 |
| 221 | 1cc | 1 |
| 222 | probtec | 2 |
| 223 | non-pfc | 1 |
| 224 | glicidic | 1 |
| 225 | c15-acetylenic | 1 |
| 226 | immuphenotypic | 1 |
| 227 | web-rhetoric | 1 |
| 228 | sortic | 1 |
| 229 | diauc | 1 |
| 230 | non-spvc | 2 |
| 231 | 580°c | 1 |
| 232 | 75-d | 1 |
| 233 | homol-d | 1 |
| 234 | 1.5h/d | 2 |
| 235 | verify3d | 1 |
| 236 | soread | 1 |
| 237 | spore-load | 1 |
| 238 | hadd | 3 |
| 239 | well-bonded | 1 |
| 240 | dil-labeled | 1 |
| 241 | nido-shaped | 1 |
| 242 | gnrh-administered | 1 |
| 243 | ultra-stabilised | 1 |
| 244 | t-terminated | 1 |
| 245 | indium-promoted | 1 |
| 246 | ch3-substituted | 1 |
| 247 | 2-oxadiazole-substituted | 1 |
| 248 | piperidine-3-ol-derived | 1 |
| 249 | mortalitysahsubarachnoid | 1 |
| 250 | 0.17-fold | 1 |
| 251 | bfmd | 1 |
| 252 | nimodipine-method | 1 |
| 253 | falsehood | 1 |
| 254 | pblood | 1 |
| 255 | stem-wood | 1 |
| 256 | wolfhard | 1 |
| 257 | safety/ae | 1 |
| 258 | smilacaceae | 1 |
| 259 | sequlae | 1 |
| 260 | thbe | 1 |
| 261 | fruit/berries/juice | 2 |
| 262 | inbalance | 1 |
| 263 | antimicrobial-performance | 1 |
| 264 | bio-tolerance | 1 |
| 265 | corrosion-resistance | 1 |
| 266 | reduction/discontinuance | 1 |
| 267 | 'coalescence | 1 |
| 268 | history/evidence | 2 |
| 269 | ovarian-hormone-dependence | 1 |
| 270 | task-dependence | 1 |
| 271 | hydration-dependence | 1 |
| 272 | inconvenience | 155 |
| 273 | provenience | 2 |
| 274 | maintanence | 1 |
| 275 | eloquence | 1 |
| 276 | hydrochlorothiazide/amiloride | 1 |
| 277 | α-l-rhamnopyranoside | 1 |
| 278 | β-d-galactopyranoside | 1 |
| 279 | nucleustide | 1 |
| 280 | millimeter/degree | 1 |
| 281 | suvrange | 6 |
| 282 | hyporreflexie | 2 |
| 283 | 5ht-uptake | 5 |
| 284 | astacin-like | 1 |
| 285 | placebolike | 1 |
| 286 | papulovesicle | 1 |
| 287 | rbc-amoxicillin-nitroimidazole | 1 |
| 288 | 3-mercapto-1,2,4-4h-triazole | 1 |
| 289 | saccule | 1 |
| 290 | byname | 1 |
| 291 | lasting-time | 2 |
| 292 | partial-thromboplastin-time | 1 |
| 293 | duration-time | 1 |
| 294 | immunome | 1 |
| 295 | rupivacaine | 1 |
| 296 | 2,6-xylidine | 1 |
| 297 | sulphamethomidine | 1 |
| 298 | fentanyl-dexmedetomidine | 2 |
| 299 | 3,5-diethynylpyridine | 2 |
| 300 | 4-chloropyridine | 1 |
| 301 | distichamine | 3 |
| 302 | chlorphenoxamine | 1 |
| 303 | suvanine | 4 |
| 304 | tyrasine | 1 |
| 305 | 4'-selenoguanosine | 1 |
| 306 | dehydroepiandrosterone/pregnenolone | 2 |
| 307 | control.none | 1 |
| 308 | aminodarone | 1 |
| 309 | cryptocoryne | 1 |
| 310 | fantastyczne | 1 |
| 311 | post-pe | 1 |
| 312 | t-3-mpe | 2 |
| 313 | rifampin-type | 1 |
| 314 | antibiotype | 4 |
| 315 | short-term.there | 1 |
| 316 | mtx.harmsthere | 1 |
| 317 | limnocythere | 1 |
| 318 | fracure | 1 |
| 319 | pellet-pressure | 1 |
| 320 | micro‑architecture | 3 |
| 321 | elecctroacupuncture | 1 |
| 322 | puericulture | 1 |
| 323 | 'ease | 4 |
| 324 | rerinse | 1 |
| 325 | neo-ι-carrahexaose | 1 |
| 326 | under-dose | 1 |
| 327 | emilienne-rose | 1 |
| 328 | 2,3-o-disulfate-d-galactose | 1 |
| 329 | feasibility-of-use | 1 |
| 330 | adolescents.because | 1 |
| 331 | touluse | 1 |
| 332 | exercise'.date | 1 |
| 333 | medline.date | 2 |
| 334 | embase.date | 2 |
| 335 | tribonate | 1 |
| 336 | spermine-nonoate | 1 |
| 337 | 3,5-dihydroxybenzoate | 2 |
| 338 | exobidentate | 1 |
| 339 | the-state | 1 |
| 340 | micromegakaryocyte | 1 |
| 341 | extra-value | 1 |
| 342 | cgi-seve | 1 |
| 343 | ethanol-responsive | 1 |
| 344 | deaurative | 1 |
| 345 | competitive-uncompetitive | 1 |
| 346 | jeff | 1 |
| 347 | whoqol-breff | 1 |
| 348 | handcuff | 1 |
| 349 | -lf | 2 |
| 350 | ms-self | 1 |
| 351 | masf | 1 |
| 352 | 300-1800μg/g | 1 |
| 353 | 29.1+/-0.8g | 1 |
| 354 | rsreg | 1 |
| 355 | 126+/-10/75+/-7mmhg | 1 |
| 356 | 0.8-1.5mg/kg | 1 |
| 357 | 553.7415mg/kg | 2 |
| 358 | 0.6mg/kg | 1 |
| 359 | carbonil/mg | 1 |
| 360 | 14u/mg | 1 |
| 361 | 5.0mg | 1 |
| 362 | 0.500mg | 1 |
| 363 | 0.24±0.04mg | 1 |
| 364 | 568mg | 1 |
| 365 | 1.9ng | 1 |
| 366 | immuno-probing | 1 |
| 367 | non-resurfacing | 1 |
| 368 | juicing | 1 |
| 369 | underloading | 1 |
| 370 | un-folding | 1 |
| 371 | displacement/folding | 1 |
| 372 | protein-retinoblastoma-binding | 1 |
| 373 | single-blinding | 3 |
| 374 | a-bonding | 1 |
| 375 | doffing | 3 |
| 376 | gfp-tagging | 1 |
| 377 | dequenching | 1 |
| 378 | time-to-hatching | 1 |
| 379 | graphing | 1 |
| 380 | self-checking | 1 |
| 381 | reassurance-seeking | 4 |
| 382 | self-annealing | 1 |
| 383 | 'doubling | 1 |
| 384 | xianling | 2 |
| 385 | air-cooling | 2 |
| 386 | throttling | 1 |
| 387 | over-scheduling | 1 |
| 388 | non-reaming | 1 |
| 389 | defattening | 1 |
| 390 | spraining | 1 |
| 391 | pteridine-containing | 1 |
| 392 | tar-staining | 1 |
| 393 | thickning | 1 |
| 394 | slave-owning | 1 |
| 395 | pace-mapping | 1 |
| 396 | fe-bearing | 1 |
| 397 | gastro-sparing | 1 |
| 398 | self-dosing | 1 |
| 399 | peptidyl-glycine-α-amidating | 1 |
| 400 | syncopating | 1 |
| 401 | investigator-rating | 1 |
| 402 | bio-prospecting | 2 |
| 403 | seed-targeting | 2 |
| 404 | postfasting | 1 |
| 405 | detorquing | 1 |
| 406 | re-living | 1 |
| 407 | merchandizing | 1 |
| 408 | clysterizing | 1 |
| 409 | sarong | 1 |
| 410 | wysong | 1 |
| 411 | b16arg | 5 |
| 412 | cost/lyg | 1 |
| 413 | 22.5μg | 1 |
| 414 | 283.5μg | 1 |
| 415 | auc0-168h/0-336h | 1 |
| 416 | holzbach | 2 |
| 417 | glücklich | 1 |
| 418 | ch4/h2-rich | 1 |
| 419 | carl-friedrich | 1 |
| 420 | 1-nh | 1 |
| 421 | alooh | 1 |
| 422 | multi-horseradish | 1 |
| 423 | intra-breath | 1 |
| 424 | hospital-length | 1 |
| 425 | nicotine-both | 1 |
| 426 | mri-lvh | 2 |
| 427 | katabi | 1 |
| 428 | entercocci | 1 |
| 429 | coryphaei | 1 |
| 430 | meshasringi | 1 |
| 431 | majhi | 3 |
| 432 | metohi | 1 |
| 433 | hurubayashi | 1 |
| 434 | shangshi | 1 |
| 435 | zozhi | 1 |
| 436 | ma-cii | 3 |
| 437 | lheidli | 1 |
| 438 | c-termini | 17 |
| 439 | placebo+folfiri | 1 |
| 440 | non-cap-lrti | 4 |
| 441 | repack | 1 |
| 442 | baxk | 1 |
| 443 | 25.3g/l | 1 |
| 444 | 0.6g/l | 1 |
| 445 | 0.7g/l | 1 |
| 446 | “pathological | 1 |
| 447 | parcial | 1 |
| 448 | optical-spatial | 1 |
| 449 | contrykal | 3 |
| 450 | dyspepsia/abdominal | 1 |
| 451 | pronominal | 1 |
| 452 | satisfaction-with-hospital | 2 |
| 453 | placement/removal | 2 |
| 454 | bax/bcl | 1 |
| 455 | parcel | 11 |
| 456 | type/level | 1 |
| 457 | axel | 1 |
| 458 | ogl | 2 |
| 459 | codas-verapamil | 1 |
| 460 | underfill | 2 |
| 461 | 350pg/ml | 1 |
| 462 | 0.65g/100ml | 1 |
| 463 | 2-methyl-2,3-butanediol | 3 |
| 464 | octasonol | 2 |
| 465 | 3h-cholesterol | 4 |
| 466 | soul | 35 |
| 467 | withdrawl | 1 |
| 468 | 19-methyl | 1 |
| 469 | l-monomenthyl | 1 |
| 470 | 3-chlorobiphenyl | 1 |
| 471 | o-n-acetyl | 1 |
| 472 | 400µl | 1 |
| 473 | septal-em/am | 1 |
| 474 | rv-em/am | 1 |
| 475 | cefepime/tazobactam | 2 |
| 476 | sm+dm | 1 |
| 477 | blandm | 1 |
| 478 | cologarithm | 1 |
| 479 | 40km | 1 |
| 480 | 15nm | 1 |
| 481 | sga-preterm | 1 |
| 482 | 8-o-acetyl-sm | 4 |
| 483 | eumorphism | 1 |
| 484 | lipoprotein-metabolism | 1 |
| 485 | symphyotrichum | 1 |
| 486 | tepidimicrobium | 1 |
| 487 | polysphaeridium | 1 |
| 488 | nickeltitanium | 1 |
| 489 | pentaruthenium | 1 |
| 490 | delphinium | 1 |
| 491 | adamussium | 1 |
| 492 | leucojum | 1 |
| 493 | pulsellum | 1 |
| 494 | receptaculum | 1 |
| 495 | maianthemum | 1 |
| 496 | craterispermum | 1 |
| 497 | neobuccinum | 1 |
| 498 | t8-sacrum | 5 |
| 499 | paracolobactrum | 1 |
| 500 | dredging-meridian | 3 |
| 501 | 'yakkan | 1 |
| 502 | kappa-carrageenan | 3 |
| 503 | makhzan | 2 |
| 504 | ydrogen | 1 |
| 505 | kaishihen | 1 |
| 506 | nhp-pain | 1 |
| 507 | seed-grain | 1 |
| 508 | acetylspiramycin | 1 |
| 509 | galiomycin | 1 |
| 510 | olkin | 4 |
| 511 | baicelin | 1 |
| 512 | sawacillin | 1 |
| 513 | capillin | 2 |
| 514 | tricellulin | 2 |
| 515 | kotalagenin | 1 |
| 516 | ovafolinin | 1 |
| 517 | bactrin | 1 |
| 518 | tomentosin | 2 |
| 519 | gem/oxaliplatin | 2 |
| 520 | dichotomitin | 1 |
| 521 | α-internexin | 1 |
| 522 | dihydralazin | 1 |
| 523 | distributionn | 1 |
| 524 | chon | 1 |
| 525 | resubmersion | 1 |
| 526 | remission/near-remission | 1 |
| 527 | identifcation | 1 |
| 528 | mispecification | 1 |
| 529 | resolidification | 3 |
| 530 | organification | 1 |
| 531 | thioesterification | 1 |
| 532 | isolation/purification | 1 |
| 533 | dsm-iv-classification | 1 |
| 534 | union-application | 1 |
| 535 | micro-location | 1 |
| 536 | retranslocation | 4 |
| 537 | refolding/degradation | 1 |
| 538 | retrogradation | 11 |
| 539 | coadministriation | 1 |
| 540 | ortho-metallation | 1 |
| 541 | coisolation | 1 |
| 542 | macrocirculation | 9 |
| 543 | bioregulation | 1 |
| 544 | don-upregulation | 1 |
| 545 | -sialylation | 1 |
| 546 | monotetrahydropyranylation | 1 |
| 547 | foxo3a-phosphorylation | 1 |
| 548 | desulfurylation | 1 |
| 549 | 3-o-monoacetylation | 2 |
| 550 | contamination/estimation | 1 |
| 551 | facilitation/co-ordination | 1 |
| 552 | detyrosination | 2 |
| 553 | repositioning/preparation | 1 |
| 554 | posthydration | 5 |
| 555 | maintenance/reverberation | 1 |
| 556 | exaceration | 1 |
| 557 | re-acceleration | 1 |
| 558 | toleration | 37 |
| 559 | hypertrophy/degeneration | 1 |
| 560 | phleboscleroobliteration | 1 |
| 561 | reinvigoration | 1 |
| 562 | time-to-deterioration | 1 |
| 563 | coevaporation | 1 |
| 564 | prescribing/titration | 1 |
| 565 | overtitration | 1 |
| 566 | overadministration | 1 |
| 567 | uration | 1 |
| 568 | p-duration | 1 |
| 569 | incidence/duration | 1 |
| 570 | kinetics/duration | 1 |
| 571 | nonstandardisation | 1 |
| 572 | 'localisation | 1 |
| 573 | near-normalisation | 1 |
| 574 | displacement/neutralisation | 1 |
| 575 | metastatisation | 1 |
| 576 | expulsation | 2 |
| 577 | precompensation | 1 |
| 578 | overinterpretation | 1 |
| 579 | neurofacilitation | 3 |
| 580 | over-exploitation | 5 |
| 581 | microcavitation | 1 |
| 582 | transcatheterimplantation | 1 |
| 583 | ara-supplementation | 1 |
| 584 | switching/augmentation | 1 |
| 585 | a53t-mutation | 1 |
| 586 | thrombocytopenia.elevation | 1 |
| 587 | π-activation | 1 |
| 588 | self-cultivation | 1 |
| 589 | solvation/desolvation | 1 |
| 590 | work-conservation | 1 |
| 591 | discomplexation | 1 |
| 592 | osteo-fixation | 1 |
| 593 | postfixation | 1 |
| 594 | geneticization | 1 |
| 595 | re-internalization | 1 |
| 596 | noninternalization | 2 |
| 597 | overgeneralization | 7 |
| 598 | infantilization | 1 |
| 599 | systemization | 1 |
| 600 | de-organization | 1 |
| 601 | homobenization | 1 |
| 602 | post-graphenization | 1 |
| 603 | hetero-dimerization | 1 |
| 604 | block-copolymerization | 1 |
| 605 | deemphasization | 1 |
| 606 | homozygotization | 1 |
| 607 | ldl-subfraction | 1 |
| 608 | 'extraction | 1 |
| 609 | trans-infection | 1 |
| 610 | washing-disinfection | 1 |
| 611 | postdisinfection | 1 |
| 612 | critical-reflection | 1 |
| 613 | supervision/direction | 1 |
| 614 | uv-detection | 1 |
| 615 | n-protection | 1 |
| 616 | underprotection | 1 |
| 617 | dys-function | 1 |
| 618 | treg-dysfunction | 1 |
| 619 | trans-junction | 1 |
| 620 | prostaglandin-induction | 1 |
| 621 | hyper-production | 1 |
| 622 | autoreproduction | 1 |
| 623 | postintroduction | 2 |
| 624 | energy-depletion | 1 |
| 625 | time-to-completion | 3 |
| 626 | heat-inhibition | 1 |
| 627 | coaddition | 1 |
| 628 | n¹-position | 1 |
| 629 | super-imposition | 1 |
| 630 | transformation/decomposition | 1 |
| 631 | acquisition/retention | 1 |
| 632 | sustention | 1 |
| 633 | non-adoption | 1 |
| 634 | dis-adoption | 1 |
| 635 | resoption | 1 |
| 636 | mixing/absorption | 1 |
| 637 | misinsertion | 1 |
| 638 | overexertion | 7 |
| 639 | remission/resolution | 1 |
| 640 | 3,4'-substitution | 1 |
| 641 | temporal-comparison | 1 |
| 642 | free-exciton | 1 |
| 643 | kanton | 1 |
| 644 | björn | 1 |
| 645 | blowdown | 1 |
| 646 | sūn | 1 |
| 647 | apico | 4 |
| 648 | deolindo | 1 |
| 649 | grbio | 1 |
| 650 | time-ratio | 1 |
| 651 | reprimo | 2 |
| 652 | ellipro | 1 |
| 653 | 183-bp | 1 |
| 654 | 11-hydroxy-nbp | 2 |
| 655 | sportsmanship | 2 |
| 656 | mid-term-follow-up | 1 |
| 657 | pseudocroup | 1 |
| 658 | sert-i612q | 1 |
| 659 | ∆acq | 1 |
| 660 | supramarginal_r | 1 |
| 661 | il-6-ar | 3 |
| 662 | papulo-nodular | 1 |
| 663 | chanesar | 4 |
| 664 | ch3mgbr | 1 |
| 665 | al7cr | 2 |
| 666 | odd-number | 1 |
| 667 | shareholder | 1 |
| 668 | cofounder | 1 |
| 669 | nontransfer | 2 |
| 670 | posttraumatischer | 1 |
| 671 | endosonography/doppler | 1 |
| 672 | jungner | 3 |
| 673 | g-browser | 1 |
| 674 | distance-to-water | 2 |
| 675 | -diameter | 2 |
| 676 | anlagebedingter | 1 |
| 677 | underpower | 1 |
| 678 | ce9afr | 3 |
| 679 | pimr | 1 |
| 680 | spo2nellcor | 1 |
| 681 | dedicator | 1 |
| 682 | instigator | 2 |
| 683 | meta-rr | 1 |
| 684 | tp/rr | 6 |
| 685 | ff+sr | 3 |
| 686 | islampur | 2 |
| 687 | second-tur | 2 |
| 688 | 17-s | 1 |
| 689 | 1000s | 2 |
| 690 | ec90s | 1 |
| 691 | lc90s | 2 |
| 692 | lt90s | 2 |
| 693 | anti-p504s | 1 |
| 694 | praxias | 1 |
| 695 | contras | 1 |
| 696 | gueltas | 1 |
| 697 | suas | 1 |
| 698 | exurbs | 1 |
| 699 | pharmacodynamics | 807 |
| 700 | psychosomatics | 5 |
| 701 | filtrates/antibiotics | 1 |
| 702 | tocopherol-to-lipids | 1 |
| 703 | wrist/hands | 1 |
| 704 | mirror-words | 4 |
| 705 | cold-tolerances | 1 |
| 706 | bio-sources | 1 |
| 707 | decabdes | 1 |
| 708 | digalactosyl-diglycerides | 1 |
| 709 | oligo-glycosides | 1 |
| 710 | 3'-c-methyl-β-d-allopyranonucleosides | 1 |
| 711 | tetraphosphopeptides | 1 |
| 712 | subsequent-hfes | 1 |
| 713 | disadvantages | 915 |
| 714 | bedclothes | 2 |
| 715 | sub-species | 2 |
| 716 | triglycerides.studies | 1 |
| 717 | conservatories | 3 |
| 718 | subregistries | 1 |
| 719 | safeties | 9 |
| 720 | centricities | 1 |
| 721 | possbilities | 1 |
| 722 | infracommunities | 1 |
| 723 | downstrokes | 1 |
| 724 | nano-scales | 2 |
| 725 | toxicity-profiles | 1 |
| 726 | high-tertiles | 1 |
| 727 | petioles | 8 |
| 728 | non-her2-genes | 2 |
| 729 | β-pinenes | 3 |
| 730 | gangrenes | 2 |
| 731 | 3-amidopiperidines | 1 |
| 732 | subsequent-lines | 1 |
| 733 | bis-hydrazones | 1 |
| 734 | phenylosazones | 1 |
| 735 | post-measures | 4 |
| 736 | time-responses | 2 |
| 737 | cirrhoses | 1 |
| 738 | disposes | 1 |
| 739 | synopses | 7 |
| 740 | short-courses | 2 |
| 741 | strengths/weaknesses | 1 |
| 742 | phosphorodiamidates | 1 |
| 743 | 21-monosulfates | 1 |
| 744 | distillates | 2 |
| 745 | under-estimates | 7 |
| 746 | 3'-phosphoramidites | 1 |
| 747 | cellulites | 3 |
| 748 | post-40-minutes | 1 |
| 749 | nonprostitutes | 1 |
| 750 | erythocytes | 2 |
| 751 | distal-halves | 1 |
| 752 | y-axes | 1 |
| 753 | z-axes | 2 |
| 754 | e-indexes | 1 |
| 755 | radixes | 1 |
| 756 | other-ratings | 1 |
| 757 | sievings | 1 |
| 758 | psychrotrophs | 1 |
| 759 | ≥6-months | 1 |
| 760 | endurance-is | 1 |
| 761 | deois | 1 |
| 762 | ostheosynthesis | 1 |
| 763 | antiogenesis | 1 |
| 764 | clonogenesis | 1 |
| 765 | substenosis | 1 |
| 766 | microfibrosis | 1 |
| 767 | pneumonia/sepsis | 1 |
| 768 | laureliopsis | 2 |
| 769 | errhysis | 1 |
| 770 | diazepam.meta-analysis | 1 |
| 771 | interanalysis | 1 |
| 772 | glutaminolysis | 5 |
| 773 | addition/protonolysis | 1 |
| 774 | steatitis | 1 |
| 775 | pseudo-outbreaks | 1 |
| 776 | 50-weeks | 1 |
| 777 | nonrisks | 1 |
| 778 | c-terminals | 3 |
| 779 | reappraisals | 5 |
| 780 | infant.models | 1 |
| 781 | c-levels | 2 |
| 782 | below-expected-levels | 1 |
| 783 | colony-levels | 1 |
| 784 | community-levels | 1 |
| 785 | mesocotyls | 1 |
| 786 | esxgms | 3 |
| 787 | harms | 2,056 |
| 788 | β-isoforms | 1 |
| 789 | esms | 1 |
| 790 | urban-slums | 1 |
| 791 | 4h-pyrans | 4 |
| 792 | energy-domains | 1 |
| 793 | hindbrains | 1 |
| 794 | resistant-strains | 1 |
| 795 | anticardiolipins | 1 |
| 796 | oralcefalosporins | 1 |
| 797 | cons | 247 |
| 798 | perceptions/opinions | 1 |
| 799 | judications | 1 |
| 800 | fracture-dislocations | 1 |
| 801 | spallations | 1 |
| 802 | anti-conformations | 1 |
| 803 | self-rationalisations | 1 |
| 804 | ortho-orientations | 1 |
| 805 | underdocumentations | 1 |
| 806 | 'representations | 1 |
| 807 | underrepresentations | 1 |
| 808 | chloroform-fractions | 1 |
| 809 | 1,4-additions | 1 |
| 810 | p-conditions | 1 |
| 811 | 8'-positions | 1 |
| 812 | 9'-positions | 1 |
| 813 | 3-positions | 3 |
| 814 | 5-positions | 6 |
| 815 | 6-positions | 3 |
| 816 | 7-positions | 4 |
| 817 | 9-positions | 1 |
| 818 | para-positions | 3 |
| 819 | 5-o-positions | 1 |
| 820 | 'perceptions | 1 |
| 821 | bastions | 1 |
| 822 | pectinifrons | 1 |
| 823 | dose-comparisons | 1 |
| 824 | 105.61tons | 1 |
| 825 | heat-patterns | 2 |
| 826 | thorns | 6 |
| 827 | p-ratios | 5 |
| 828 | cf3-dps | 3 |
| 829 | zc-fdps | 1 |
| 830 | epidemiology-bips | 1 |
| 831 | mdkrps | 1 |
| 832 | nonmembers | 1 |
| 833 | farm-numbers | 1 |
| 834 | non-shedders | 1 |
| 835 | nonwelders | 1 |
| 836 | ∼3-orders | 1 |
| 837 | enablers | 26 |
| 838 | beta-epimers | 1 |
| 839 | s-enantiomers | 14 |
| 840 | 4,9-isomers | 1 |
| 841 | beamformers | 2 |
| 842 | non-snorers | 1 |
| 843 | everusers | 1 |
| 844 | urine-parameters | 2 |
| 845 | non-receivers | 3 |
| 846 | micron-flowers | 2 |
| 847 | delayers | 1 |
| 848 | eliminators | 1 |
| 849 | lifestyle-factors | 2 |
| 850 | crp-predictors | 1 |
| 851 | at2-receptors | 2 |
| 852 | distributors | 24 |
| 853 | ruggedness | 5 |
| 854 | client-centeredness | 1 |
| 855 | interrelatedness | 6 |
| 856 | eveness | 1 |
| 857 | regressiveness | 1 |
| 858 | value/effectiveness | 1 |
| 859 | addictiveness | 11 |
| 860 | cost-effictveness | 1 |
| 861 | flabbiness | 1 |
| 862 | safetiness | 1 |
| 863 | slackness | 1 |
| 864 | width/thickness | 1 |
| 865 | scientificalness | 3 |
| 866 | faithfulness | 5 |
| 867 | hoarsness | 1 |
| 868 | innocuousness | 3 |
| 869 | saltness | 1 |
| 870 | recentness | 1 |
| 871 | inaptness | 1 |
| 872 | safetyness | 1 |
| 873 | cryo-stress | 1 |
| 874 | fatigue/loss | 1 |
| 875 | cost-effectivenesss | 1 |
| 876 | trait-effects | 1 |
| 877 | giblets | 2 |
| 878 | lengths/heights | 1 |
| 879 | freedom/rights | 1 |
| 880 | α2-subunits | 1 |
| 881 | demerits | 12 |
| 882 | spirituality.results | 1 |
| 883 | paris.participants | 1 |
| 884 | news-recipients | 4 |
| 885 | post-measurements | 2 |
| 886 | 3'-fragments | 1 |
| 887 | mid-segments | 5 |
| 888 | adverse-events | 5 |
| 889 | phlebotomists | 1 |
| 890 | pneumocysts | 1 |
| 891 | catguts | 1 |
| 892 | sister.marcus | 1 |
| 893 | anisodus | 1 |
| 894 | brahman-angus | 4 |
| 895 | pitangus | 1 |
| 896 | sophus | 1 |
| 897 | hybanthus | 1 |
| 898 | sphenodesmus | 1 |
| 899 | torynurus | 1 |
| 900 | mrxs | 1 |
| 901 | 9days | 1 |
| 902 | protégés | 1 |
| 903 | sickness-impact | 1 |
| 904 | side-effect | 489 |
| 905 | effect/side-effect | 1 |
| 906 | ea-dt | 1 |
| 907 | creutzfeldt | 1 |
| 908 | hetero-fret | 1 |
| 909 | -benefit | 1 |
| 910 | arabic-dominant | 1 |
| 911 | deferred/adjuvant | 1 |
| 912 | primer-dependent | 1 |
| 913 | under-enhancement | 1 |
| 914 | reenforcement | 1 |
| 915 | 'reinforcement | 1 |
| 916 | non-requirement | 1 |
| 917 | self-fulfillment | 2 |
| 918 | sustainment | 8 |
| 919 | overdevelopment | 1 |
| 920 | disempowerment | 2 |
| 921 | postassesment | 1 |
| 922 | midazolam.assessment | 1 |
| 923 | ifn-γ-treatment | 1 |
| 924 | balm-mint | 1 |
| 925 | zygmunt | 1 |
| 926 | ghareghoroot | 1 |
| 927 | id-test | 1 |
| 928 | after-test | 1 |
| 929 | actitest | 3 |
| 930 | concealment.most | 1 |
| 931 | 'jadu | 1 |
| 932 | ser80leu | 1 |
| 933 | jinghou | 1 |
| 934 | tanyu | 1 |
| 935 | madhav | 1 |
| 936 | wladyslaw | 1 |
| 937 | tatarinow | 1 |
| 938 | da/dtmax | 3 |
| 939 | temenothorax | 1 |
| 940 | gl-ex | 2 |
| 941 | homa-ir-index | 1 |
| 942 | bapwv/caix | 1 |
| 943 | lomflox | 1 |
| 944 | livertox | 1 |
| 945 | clpx | 2 |
| 946 | mpqx | 4 |
| 947 | influx/efflux | 1 |
| 948 | minimizing-by | 1 |
| 949 | biopiracy | 3 |
| 950 | multiplicity/redundancy | 1 |
| 951 | tissue-dependency | 1 |
| 952 | inter-dependency | 3 |
| 953 | pertinency | 1 |
| 954 | libido/potency | 1 |
| 955 | microbody | 3 |
| 956 | after-study | 1 |
| 957 | robins-mark-newey | 1 |
| 958 | 'stuffy | 1 |
| 959 | 65gy | 1 |
| 960 | polypharmacology | 8 |
| 961 | autecology | 1 |
| 962 | teleology | 1 |
| 963 | pathopsychology | 1 |
| 964 | clinico-pathomorphology | 1 |
| 965 | venerology | 1 |
| 966 | peritoneography | 1 |
| 967 | choreography | 1 |
| 968 | iconography | 3 |
| 969 | pedobarography | 1 |
| 970 | mechanomyography | 3 |
| 971 | cytotoxictiy | 1 |
| 972 | described-mainly | 1 |
| 973 | uretectomy | 1 |
| 974 | uretero-vesiconeostomy | 1 |
| 975 | peg-ifn/rbv-therapy | 1 |
| 976 | bribery | 2 |
| 977 | psychosurgery | 1 |
| 978 | anti-geometry | 1 |
| 979 | cytotoxicicty | 1 |
| 980 | tolerability/safety | 7 |
| 981 | mutagenecity | 1 |
| 982 | non-specificity | 7 |
| 983 | ethicity | 1 |
| 984 | reactogenicity | 298 |
| 985 | safety/reactogenicity | 5 |
| 986 | diabetogenicity | 6 |
| 987 | thermo-electricity | 1 |
| 988 | denticity | 1 |
| 989 | pseudo-elasticity | 1 |
| 990 | magnetoelasticity | 1 |
| 991 | eco-toxicity | 2 |
| 992 | safety/toxicity | 7 |
| 993 | unhomogeneity | 1 |
| 994 | bilaterality | 9 |
| 995 | 3=duality | 1 |
| 996 | wonca-quality | 1 |
| 997 | mcgill-quality | 1 |
| 998 | process-quality | 1 |
| 999 | biological/quality | 1 |
| 1000 | work-ability | 4 |
| 1001 | prescribability | 2 |
| 1002 | spreadability | 5 |
| 1003 | avoidability | 1 |
| 1004 | affordability | 98 |
| 1005 | unaffordability | 1 |
| 1006 | recyclability | 10 |
| 1007 | nonrecyclability | 1 |
| 1008 | actionability | 1 |
| 1009 | wearability | 4 |
| 1010 | tolerability | 7,958 |
| 1011 | neurotolerability | 1 |
| 1012 | torerability | 1 |
| 1013 | ameliorability | 1 |
| 1014 | reusability | 22 |
| 1015 | translatability | 11 |
| 1016 | alkali-extractability | 1 |
| 1017 | meltability | 3 |
| 1018 | intra-reproducibility | 1 |
| 1019 | edibility | 10 |
| 1020 | comprehensibility | 18 |
| 1021 | unavailablility | 1 |
| 1022 | hypermotility | 2 |
| 1023 | auc0infinity | 2 |
| 1024 | co-linearity | 1 |
| 1025 | multidisciplinarity | 1 |
| 1026 | sum-severity | 1 |
| 1027 | nature/severity | 1 |
| 1028 | number/severity | 1 |
| 1029 | development/university | 1 |
| 1030 | semi-quantity | 1 |
| 1031 | hyperadhesivity | 1 |
| 1032 | permissivity | 1 |
| 1033 | exclusivity | 79 |
| 1034 | pten-negativity | 1 |
| 1035 | associativity | 2 |
| 1036 | hyper-activity | 1 |
| 1037 | gpx-activity | 3 |
| 1038 | β2-selectivity | 1 |
| 1039 | cardio-selectivity | 1 |
| 1040 | regioslectivity | 1 |
| 1041 | pseudopositivity | 1 |
| 1042 | qualty | 1 |
| 1043 | tolerabilty | 1 |
| 1044 | acceptabililty | 1 |
| 1045 | chaetotaxy | 2 |
| 1046 | 2000hz | 1 |
| 1047 | 1134khz | 1 |
| 1048 | włodzimierz | 1 |
| 1049 | auct-∞ | 3 |
| 1050 | ascensia® | 2 |
| 1051 | corneal® | 1 |
| 1052 | 135° | 13 |
| 1053 | 85.36° | 1 |
| 1054 | hsp90/grα | 2 |
| 1055 | il‑β | 1 |
| 1056 | corporació | 1 |
| 1057 | igκ | 2 |
| 1058 | alsо | 1 |